IDH2 Mutation-Contribute -1.0
Pathway-Reported -1.0
Phosphorylation-THREONINE 0.1111
Drive-Reported -1.0
Growth arrest-TERM -1.0
Endodermal-Transcript -1.0
Identified-HEPATOCELLULAR CARCINOMA -1.0
Oct-4-Murine -1.0
Occur-Genomic -1.0
Block-LEAD -1.0
Detected-Maturation -1.0
Proteasome-Responsible -1.0
caspase activity-Show -1.0
IDH-Enzymatic Activity -1.0
Chips-DATA SET -1.0
GATA2-Ionising radiation -1.0
Drug Resistance-Tumors 0.1429
TET2-IDH1 Mutation -1.0
ABT-737-derivatives -1.0
hTERT-Cell Growth -1.0
TREAT-Permit -1.0
-- Leukemia-IRS-1 0.0
Proteolysis-Rodent 0.0833
Cancer-telomerase activity -1.0
Interest-bind -1.0
Activated-Cultured Cells -1.0
IL1-Anaphase Promoting Complex -1.0
RAS-TERM -1.0
Human-Transfection 0.0588
Selection-neoplastic transformation -1.0
Pancreatic Cancer-Stimulated -1.0
Homologous Sequences-Reported -1.0
20%-Drive -1.0
Flow-GATA2 -1.0
Process-TUMORIGENICITY -1.0
studies-DATA SET -1.0
Cells-Normal cell division -1.0
Examined-Tumors -1.0
Embryonal Carcinoma Cell-Embryoid Bodies 0.3333
LEAD-Enhance -1.0
Thought-EVENTS -1.0
Catalytic-IDH2 -1.0
Cyclin-D1-Mammalian Cell -1.0
Aurora-A kinase-LATS2 -1.0
Lanugo-ACUTE MYELOGENOUS LEUKEMIA -1.0
LATS2-LATS1 -1.0
MICROARRAY-VARIOUS -1.0
Mutant-Library -1.0
Pitta-MIR-21 -1.0
studies-cells differentiation -1.0
Breast Cancer-Head 0.2
KRAS-inhibitors -1.0
Cyclin-D1-degradation of cyclin -1.0
Alone-Advance -1.0
Selected-Myelopoiesis -1.0
Mutant-STANDING -1.0
ABT-737-Regression -1.0
Human-Thought -1.0
RAS Oncogene-Responsible -1.0
TAK1-Pathway -1.0
ANALYSIS-Embryonic Stem Cells 0.1111
GATA2-Enhance -1.0
Human-Gene Mutation -1.0
Phosphorylation-degradation of cyclin -1.0
FUNCTIONS OF REPRODUCTION-Degraded -1.0
Show-Drive -1.0
-- Leukemia-Tumors 0.0
Proliferative-Stimulated -1.0
Kinase-Consideration -1.0
Reported-LATS -1.0
Cyclin-D1-Reported -1.0
Myeloid Differentiation-RNAi -1.0
Account #-AS gene 0.0
Detected-CDK5RAP2 -1.0
AN-MDM2 -1.0
Study-Granulopoiesis -1.0
Bcl-2-Reported -1.0
Cyclin-Dependent Kinases-Senescence -1.0
PPP-Synthetic -1.0
Embryonal Carcinoma Cell-Embryonic Stem Cells 0.5
Process-Phenotype -1.0
Tumor cells-Cell metabolism -1.0
Endodermal-POU5F1 -1.0
Mouse, NOS-Enhance -1.0
Mutant-depend -1.0
KRAS-look -1.0
-- Leukemia-Show 0.0
Development-Phenotype -1.0
Activated-Homologous -1.0
TET2-shRNA -1.0
TET2-Differentiation -1.0
pRB-Thought -1.0
Catalytic-Promoter -1.0
Activated-Ras proteins -1.0
Ectodermal-Transcript -1.0
Entry-Cell Lines -1.0
Production-Lead 2+ 0.0
Immortalized-Cell metabolism -1.0
virus infection-caspase activity -1.0
Cancer-Lethal -1.0
Phosphorylation-Ubiquitination 0.2
GATA2-Defined -1.0
Regulation-Maturation -1.0
Progression-Homolog -1.0
DEATH-Death Receptors 0.0909
Tumors-ENZYMES 0.1667
Papillary Carcinoma of the Thyroid-LATS2 -1.0
NIH 3T3 Cells-Cellular Stress Response -1.0
Phosphorylation-Study -1.0
Oncogene-Suppressor -1.0
Mouse, NOS-Embryonic Stem Cells -1.0
KRAS-Carrying -1.0
LEAD-bind -1.0
Differentiation-Embryonic Stem Cells -1.0
Tumor regression-RAS -1.0
Bcl-2-apoptotic cell death -1.0
LATS2-Interphase -1.0
TREAT-Tumor cells -1.0
Promote-LEAD -1.0
P53-Show -1.0
CERVICAL CANCER-metastasis 0.25
FUNCTIONS OF REPRODUCTION-PROTEIN -1.0
IDH2 Gene-Redundant -1.0
TAK1-Mutation -1.0
Tumor cells-Researchers -1.0
Process-EVENTS -1.0
Mouse, NOS-VARIOUS -1.0
combinations-Responsible -1.0
GATA6-Checkpoint -1.0
PC9-Show 0.0
Examined-FASUDIL -1.0
Published-Companions -1.0
IDH-Regulation -1.0
Transcriptional Networks-CO 0.0909
Chromatin-PROTEINS 0.3333
Catalytic-Isocitrate Dehydrogenase -1.0
Cancer-EVENTS -1.0
TISSUE-TUMORIGENICITY -1.0
WT1-Protein A 0.1111
Development-Absence -1.0
metastasis-Reports -1.0
Cyclin-Dependent Kinase Inhibitor-Work -1.0
Erythropoiesis-Mice 0.0588
Cancer-Signaling Molecule -1.0
Regulated-PROTEINS -1.0
Monitor-MIR-145 -1.0
ACT-Reported -1.0
Feedback-Transcription -1.0
Occur-Phenomena -1.0
IDH1-Transformation -1.0
in vitro study-Lanugo -1.0
Epigenetic Change-Represent -1.0
Regulation-Study -1.0
Regression-Reported -1.0
virus infection-Necrotic -1.0
PROTEIN-Work -1.0
Entry-Oncogens -1.0
metastasis-Tumors 0.3333
Interest-Enhance -1.0
AML-Mutations 0.125
Oct-4-Ectodermal -1.0
TREAT-Result -1.0
Signaling Pathways-Pathways -1.0
Aurora-A kinase-Cell Growth -1.0
Oct-4-Embryoid Bodies -1.0
Drive-HOPX -1.0
Mutations-Promoter -1.0
Regulation-ATRA -1.0
Mutations-Metabolite -1.0
Pathways-Viability, Cell -1.0
TET2-Reported -1.0
DEATH-ABLATION -1.0
Adenocarcinoma of the Lung-RAS -1.0
Stem-LED -1.0
compromise-Caspase 8 gene -1.0
RIP1-Homologous Sequences -1.0
DEATH-Caspase Inhibitors 0.0769
Occur-cumulative gene -1.0
MIR-21-algorithm -1.0
Binding-P53 -1.0
TET2-Progenitor Cell proliferation -1.0
NSCLC-Viability, Cell 0.0909
Tumorigenesis-Cancer -1.0
Aurora-A-Show -1.0
Human cells-Cells -1.0
ESC-Embryonic Stem Cells -1.0
Oct-4-Plasmid -1.0
Reports-RNA -1.0
Regression-Block -1.0
Monitor-Show -1.0
Mutant-Fulfill -1.0
Selection-Represent -1.0
Human-Retinoblastoma Protein 0.0588
Lesion-Individual -1.0
miRNA--- Lung Cancer 0.0
LEAD-Stem Cells 0.1111
TET2 Gene-Survey -1.0
Cell Lines-Models -1.0
Carrying-Fulfill -1.0
Very Important-Process -1.0
Human-TUMOR TISSUE -1.0
PROTEIN-resistance Determinant -1.0
WAS-Human 0.0625
TET2-Isocitrate Dehydrogenase -1.0
Bcl-2-FAMILY MEMBER -1.0
Murine-Carcinoma, Embryonal -1.0
Reported-Promoter -1.0
Human-Reagent -1.0
Mutant-kill -1.0
Inhibition-Permit -1.0
CCAAT Enhancer Binding Protein-miRNAs 0.1111
DNA hypermethylation-Isocitrate Dehydrogenase -1.0
Occur-Tumors -1.0
EGFR-PROTEINS -1.0
miRNA-Tumors 0.125
Repression-Retinoblastoma 0.125
ES-CO 0.25
EC Cell-Up-Regulation -1.0
NSCLC-Researchers 0.1
G1 Arrest-Proteolysis -1.0
Phosphorylation-MIR-145 -1.0
Study-Cells -1.0
Cell Cycle Progression-Progression -1.0
G2/M Transition-LATS1 -1.0
KRAS-Pathways -1.0
Necrotic-necrotic cell death -1.0
RNA Interference-Result -1.0
Interest-TRAF6 -1.0
Oct-4-DATA SET -1.0
Viability, Cell-Checkpoint -1.0
Examined-study use -1.0
Promote-Mesodermal -1.0
Identified-NSCLC -1.0
ES-Reagent -1.0
Transcription Factors-Feedback 0.1
Reported-Genomic -1.0
ES-Cells 0.1667
Myelopoiesis-Human 0.0526
Identified-Show -1.0
Plays-PLK1 -1.0
CERVICAL CANCER-COLON CANCER 0.3333
Senescence-RAS Oncogene -1.0
CERVICAL CANCER-Breast Cancer 0.3333
LEAD-fight -1.0
Oct-4-Microarray Analysis -1.0
Mesodermal-Chromatin Structure -1.0
Very Important-Drug Discovery -1.0
Senescence-TERM -1.0
Proliferative-LATS2 -1.0
Lanugo-resistance Determinant -1.0
Phosphorylation-Take -1.0
Plays-CDK5RAP2 -1.0
inhibitors-kinase activity -1.0
Cell Growth-LATS -1.0
Show-Hallmark Cell -1.0
Lethal-Protein A 0.0833
Human-Aurora-A -1.0
Catalytic-Enzymatic Activity -1.0
Human-Tumors 0.0714
-- Leukemia-Clear cell Kidney Cancer 0.0
Mouse, NOS-TRAF6 -1.0
Elimination--- Lung Cancer 0.0
Reported-Block -1.0
KRAS-Human gene -1.0
signalling-Cells -1.0
Regulation-Roles -1.0
Transcriptional Networks-Repression 0.0909
Transformation-Regulation -1.0
Mutant-GATA2 -1.0
metastasis-Carcinoma, Thyroid 0.25
Signaling Pathways-Mice -1.0
shRNA-RNAi -1.0
Viability, Cell-Tumorigenesis 0.1111
System-Regulation -1.0
State-Block -1.0
Relapsing-HEPATOCELLULAR CARCINOMA -1.0
Show-Mouse, NOS -1.0
cancer screen-depend -1.0
Actin-PROTEINS 0.25
Researchers-Viability, Cell 0.125
-- Leukemia-INSULIN RECEPTOR SUBSTRATE 1 0.0
EC Cell-Reagent -1.0
Differentiation-Pluripotent Stem Cell -1.0
LATS2-Papillary Thyroid Carcinoma -1.0
studies-ENZYMES -1.0
Regulated-EGFR -1.0
regulation of ribosome biogenesis-Proteolysis -1.0
Mutant-research results -1.0
Identified-LYMPHOMA -1.0
ANALYSIS-Cell types -1.0
Mutation-Kinase 0.1
anti-apoptosis-ABT-737 -1.0
Papillary Carcinoma of the Thyroid-CYCLIN E -1.0
Mcl-1-anti-apoptosis -1.0
Identified-Drive -1.0
Mutations-IDH2 -1.0
Mutations-Isocitrate Dehydrogenase 0.0833
-- Leukemia-CHRONIC LYMPHOCYTIC LEUKEMIA 0.0
pRB-Growth arrest -1.0
Mutations-Block -1.0
ACUTE MYELOGENOUS LEUKEMIA-Occur -1.0
Reported-centrosomin -1.0
bcl-xL-Reported -1.0
Drive-Represent -1.0
Identified-Tumors -1.0
mek-Pathway -1.0
studies-Transformation -1.0
Progression--- Lung Cancer 0.0
TET2-IDH2 Mutation -1.0
RAS Oncogene-Anaphase Promoting Complex -1.0
TBK1-Mutation -1.0
Caco-2 Cells-Construct -1.0
IDH1-Mutations -1.0
Transcriptional Network-D1 -1.0
Transcriptional Networks-Renilla 0.0714
Mouse, NOS-Plasmid -1.0
mir-223-Comprise -1.0
Selection-Epigenetic -1.0
Mouse, NOS-GATA2 Transcription Factor -1.0
Rest-Tumor Suppressor -1.0
Relapsing-CHRONIC LYMPHOCYTIC LEUKEMIA -1.0
mir-223-ANIMAL -1.0
ABT-737-bcl-xL -1.0
Occur-IDH1 -1.0
OVARIAN CANCER-LATS2 -1.0
Genotoxic Stress-Proteolysis -1.0
used-Genes -1.0
Examined-Patients -1.0
caspase activity-Death Receptors -1.0
MCF-Analyzed -1.0
Relapsing-INSULIN RECEPTOR SUBSTRATE 1 -1.0
MICROARRAY-DATA SET -1.0
Promote-POU5F1 -1.0
Identified-Tumor cells -1.0
-- Leukemia-LYMPHOMA 0.0
Take-serine/threonine-protein kinase -1.0
Thought-Genesis -1.0
Retinoblastoma Protein-Genesis -1.0
Monitor-Cell Proliferation -1.0
Adenocarcinoma of the Lung-Development -1.0
Rest-Neural Tumors -1.0
Senescence-Tumor Suppressor -1.0
derivatives-Block -1.0
compromise-necrotic cell death -1.0
Tumors-Thought -1.0
Progenitor Cell proliferation-mediated -1.0
mir-223-transcription factor Nuclear Factor I -1.0
Plays-Cell Cycle -1.0
CERVICAL CANCER-Clear cell Kidney Cancer -1.0
Cyclin-Dependent Kinases-Fibroblasts 0.1
Oct-4-Cells -1.0
Cancer-TUMOR -1.0
Telophase-N NOS -1.0
KRAS-Signaling Pathways -1.0
ANALYSIS-VARIOUS -1.0
Phosphorylation-Proteolytic -1.0
Genes-Pathways -1.0
miRNAs-Human Development 0.1111
G2/M Arrest-Anaplastic Thyroid Cancer -1.0
ESC-VARIOUS -1.0
RNA Interference-depend -1.0
Related-Mice -1.0
Oct-4-Carcinoma, Embryonal -1.0
HOPX-centrosomin -1.0
Stem-commitment -1.0
Cancer-Cytotoxic -1.0
AN-P19 -1.0
studies-IDH -1.0
AN-P14 -1.0
GATA2-Regulated -1.0
Breast Cancer-Carcinoma, Thyroid 0.3333
LATS2-Activated -1.0
RNA Interference-Permit -1.0
Stem-used -1.0
in vitro study-used -1.0
TET2-RNAi -1.0
Cyclin-Dependent Kinase Inhibitor-Model System -1.0
Differentiated-Carcinoma, Embryonal -1.0
Cyclin-D1-Study -1.0
Adopted-Line -1.0
Binding-Stimulated -1.0
necroptosis-caspase activity -1.0
Electroporation-Western Blotting 0.25
P53-Activate -1.0
regulation of ribosome biogenesis-MDM2 -1.0
Cells-Functional Component -1.0
Viability, Cell-localisation -1.0
Inhibition-Result -1.0
Actin-Complexes -1.0
ES-Microarray Analysis 0.125
ABLATION-LUNG TUMOR -1.0
Breast Cancer-COLON CANCER 0.3333
Tumorigenesis-Researchers 0.125
CERVICAL CANCER-Oncogene 0.0833
mir-223-Regulated -1.0
EC Cell-Microarray Analysis -1.0
CCAAT Enhancer Binding Protein-Comprise -1.0
Reported-Model System -1.0
EVENTS-INTERMEDIATE -1.0
Differentiated-Expression Profiling -1.0
Human-TUMOR 0.0714
study use-VARIOUS -1.0
Mice-Reported -1.0
hTERT-Hallmark Cell -1.0
Aurora-A kinase-Show -1.0
Lanugo-Model System -1.0
Genes-Researchers 0.1
TET2-Phenotype -1.0
Senescence-Cellular Stress Response -1.0
Mutant-Pathways -1.0
Centrosomes-miRNA 0.0667
Elimination-Advance -1.0
Work-Cell Differentiation 0.125
Response-overexpress -1.0
Contribute-cervical cancers -1.0
Cell Cycle Arrest-Oncogens -1.0
Regulation-NB4S -1.0
Ectodermal-Plays -1.0
Computational-used -1.0
LEAD-GATA2 Transcription Factor 0.1
Take-lead increased -1.0
Oct-4-Published -1.0
Human cells-UTR -1.0
Cells-Tumorigenesis 0.1429
KRAS-c-Raf -1.0
Oncogene-Deregulation -1.0
Mammalian-VARIOUS -1.0
Detected-Regulated -1.0
Reported-Show -1.0
Genes-NSCLC 0.0769
Comparison-KRAS -1.0
Transcriptional Network-Responsible -1.0
Mesodermal-Stem Cells -1.0
TET2-Lead 2+ 0.0
Caco-2 Cells-Protein Expression -1.0
Inhibiting-cervical cancers -1.0
Contribute-Regulation -1.0
Cyclin-D1-Show -1.0
Aurora-A kinase-MIR-21 -1.0
Human-Exhibit -1.0
Phenomena-cumulative gene -1.0
Library-GATA2 -1.0
mir-223-System -1.0
Chips-Cell types -1.0
IDH2 Gene-IDH1 -1.0
CCAAT Enhancer Binding Protein-Transcription Factors 0.3333
NF1-Feedback 0.0909
TET2 Gene-Clarified -1.0
Myeloid Differentiation-Lanugo -1.0
Work-Cells 0.1667
KRAS-RAS -1.0
strategies-PROTEIN -1.0
Researchers-Reported -1.0
TET2-IDH2 -1.0
TET2-IDH1 -1.0
Deletion-play -1.0
Examined-NSCLC -1.0
Elimination-research results -1.0
Cancer-E2F-1 -1.0
Tumor Suppressor Proteins-Gene Mutation -1.0
Examined-Treated with -1.0
Breast Cancer-Human 0.0667
Oct-4-ESC -1.0
lung tumors-Tumors regression -1.0
pRB-Fibroblasts -1.0
Growth arrest-Activated -1.0
necroptosis-DEATH -1.0
GATA2-Signaling Pathways -1.0
Roles-Human Development 0.2
Human-Individual -1.0
Actin-VARIOUS -1.0
regulation of ribosome biogenesis-ligase inhibitor -1.0
HOPX-NDEL1 -1.0
Cell Cycle Progression-Consideration -1.0
HeLa-Western Blotting -1.0
Human-Microarray Analysis 0.0625
Elimination-Represent -1.0
Reported-Proteolysis -1.0
Selection-TISSUE -1.0
KRAS-Result -1.0
Primitive-Chromatin Structure -1.0
CERVICAL CANCER-Aurora-A -1.0
Cancer-Genesis -1.0
Differentiation-tumor growth -1.0
Alone-Represent -1.0
Reported-Redundant -1.0
CERVICAL CANCER-Roles 0.1111
Chemical-necrotic cell death -1.0
Show-Examined -1.0
Fibroblasts-Cells 0.3333
Oncogene-Malignant -1.0
LATS2-Homologous -1.0
Show-APC -1.0
Mcl-1-ABT-737 -1.0
EGFR-Aurora-A -1.0
Show-play -1.0
GATA2-Reported -1.0
compromise-ABLATION -1.0
TET2-Myeloid Differentiation -1.0
Cell Growth-PROTEINS -1.0
Mitosis-LATS1 -1.0
Show-Cell Survival -1.0
Flow-Synthetic -1.0
Promote-Primitive -1.0
OVARIAN CANCER-Stimulated -1.0
Murine-Cell types -1.0
TRAF6-Lung Infection -1.0
Adopted-All-trans Retinoic Acid -1.0
Mammalian-Related -1.0
TBK1-Permit -1.0
Fibroblasts-State -1.0
Elimination-STANDING -1.0
solid tumors-Block -1.0
these-ACT -1.0
Centrosomes-Show -1.0
G1 Arrest-studies -1.0
Subunit-VARIOUS -1.0
Report-Cell Proliferation -1.0
Cell types-Tumor Progression -1.0
Mutant-Result -1.0
GATA2-Pathway -1.0
Show-AKT -1.0
Account #-Lethal 0.0
Reported-IDH1 Mutation -1.0
Thought-TUMORIGENICITY -1.0
Adenocarcinoma of the Lung-Promoter -1.0
Oct-4-Maintain -1.0
Phosphorylation Site-D1 -1.0
ABT-737-Cancer -1.0
MCF-Construct -1.0
Block-Growth arrest -1.0
Bcl-2-Regression -1.0
Mouse, NOS-DATA SET -1.0
Activated-RAS Oncogene -1.0
metastasis-LYMPHOMA 0.25
combinations-Anaphase Promoting Complex -1.0
Proteolysis-Senescence -1.0
GATA2-Genes -1.0
apoptotic cell death-Cytotoxic -1.0
Promote-Transcript -1.0
Cell Cycle Progression-Telophase -1.0
Cyclin-D1-APC -1.0
Caco-2 Cells-MCF7 -1.0
Proliferative-overexpress -1.0
Regulation-localisation -1.0
Mutant-Regulated -1.0
Cell Cycle Progression-Anaphase -1.0
Entry-Show -1.0
MDM2-Senescence -1.0
Mouse, NOS-Study -1.0
Cell Lines-KRAS -1.0
Cell types-Understand -1.0
Cyclin-D1-Proteolysis -1.0
PC9-Process 0.0
Occur-neoplastic transformation -1.0
Necrotic-Process -1.0
TET2-AML -1.0
apoptotic cell death-Anaplastic Thyroid Cancer -1.0
Chips-Embryonic Stem Cells -1.0
Senescence-Ras proteins -1.0
Mcl-1-ACUTE MYELOGENOUS LEUKEMIA -1.0
ABT-737-Reported -1.0
mir-223-Show -1.0
Target Gene-used -1.0
bcl-xL-depend -1.0
Binding-overexpress -1.0
WAS-Transformation -1.0
ES-UTR -1.0
Transcriptional Networks-Reports -1.0
studies-Embryoid Bodies -1.0
Murine-cells differentiation -1.0
P53-regulation of ribosome biogenesis -1.0
Progression-Very Important -1.0
Oncogene-Transformation -1.0
Cancer-Tumors -1.0
LEAD-LUNG TUMOR -1.0
Oct-4-Up-Regulation -1.0
Production-Block -1.0
Screen-Show -1.0
Promote-Progenitor -1.0
Human-CDK5RAP2 -1.0
strategies-Response -1.0
Cells-Cellular Stress Response -1.0
Cancer-Synthetic -1.0
-- Lung Cancer-Drug Discovery 0.0
Tumors-IDH -1.0
GATA2-Lethal -1.0
Cell Growth-localisation -1.0
ESC-DATA SET -1.0
System-Line -1.0
GATA2-D1 -1.0
System-Promoter -1.0
Centrosomes-studies -1.0
Show-Characterized -1.0
KRAS-human cell lines -1.0
Carbon-Models -1.0
cancer screen-Pathway -1.0
P53-Ubiquitin 0.0833
Work-NB4S -1.0
Cells-GTP 0.1111
ACT-Tumor specimens -1.0
Relapsing-Oncogene -1.0
miRNA-Clear cell Kidney Cancer -1.0
Transcriptional Networks-Microarray Analysis 0.0909
PPP-GATA2 -1.0
TREAT-PC9 0.0
Tet-cervical cancers -1.0
MICROARRAY-Cell types -1.0
Cell Growth-Activities -1.0
Chromatin-Related -1.0
NSCLC-Library 0.0909
Drive-Responsible -1.0
GATA2-GATA6 -1.0
EC Cell-Repression -1.0
Tissues-P19 -1.0
Human cells-SEQUENCING -1.0
Phosphorylation-Roles 0.1
Tissues-P14 -1.0
Account #-KRAS 0.0
Leukemic Cells-IDH2 -1.0
Identified-Anaphase Promoting Complex -1.0
Branch-Synthetic -1.0
Selection-Thought -1.0
Epigenetic-neoplastic transformation -1.0
Mcl-1-Cytotoxic -1.0
Differentiation-Stem Cells -1.0
TET2-IDH -1.0
Process-cumulative gene -1.0
Micro-tubule-studies -1.0
Cancer-hTERT -1.0
Stem-Lanugo -1.0
Tumor cells-inhibitors -1.0
Examined-BORTEZOMIB -1.0
Development-Normal cell division -1.0
Carbon-Drive 0.1111
Researchers-PC9 0.0
Show-degradation of cyclin -1.0
TRANSCRIPTION FACTOR-Enhance -1.0
Agent-striking -1.0
Ionising radiation-Proteolysis -1.0
NSCLC-Cell Growth -1.0
AN-regulation of ribosome biogenesis -1.0
System-Study -1.0
Mcl-1-Tumor cells -1.0
Crassa-Homolog -1.0
Human cells-Renilla -1.0
Differentiation-Cell types -1.0
Reported-2-HG -1.0
Reported-Papillary Thyroid Carcinoma -1.0
Mouse, NOS-cells differentiation -1.0
Development-neoplastic transformation -1.0
shRNA-mediated -1.0
Differentiated-ANALYSIS -1.0
Primitive-Transcript -1.0
Caveat-Drug Discovery -1.0
Drug Resistance-model -1.0
Report-MIR-145 -1.0
IL1-Responsible -1.0
Inhibition-Pathway -1.0
Cells-PROTEINS 0.1667
LATS2-Cell Growth -1.0
mir-223-Human Development -1.0
Cyclin-Dependent Kinases-INK4a -1.0
Human-Maturation -1.0
Progenitor-Chromatin Structure -1.0
Mutant-Very Important -1.0
MICROARRAY-Embryonic Stem Cells -1.0
Tumor cells-lead increased -1.0
Epigenetic Change-neoplastic transformation -1.0
CAAT-Enhancer Binding Protein-transcription factor Nuclear Factor I -1.0
Development-Phenomena -1.0
model-bind -1.0
NSCLC-Fulfill -1.0
LATS2-G2/M Transition -1.0
Mice-Characterized -1.0
Identified-Reports -1.0
Ubiquitination-THREONINE 0.0833
mediated-LEAD -1.0
Caveat-Process -1.0
Block-Senescence -1.0
mediated-Oncogens -1.0
Cell Cycle Progression-N NOS -1.0
Telophase-Homolog -1.0
Leukemic Cells-Lead 2+ 0.0
pRB-ligase inhibitor -1.0
P53-Tumor Suppressor Proteins 0.0833
Take-Cell metabolism -1.0
KRAS-Lethal -1.0
Oct-4-Difference stage -1.0
Subunit-ATP-dependent chromatin remodeling -1.0
CERVICAL CANCER-Breast Cancer Cell -1.0
IL1-degradation of cyclin -1.0
Show-Cell metabolism -1.0
RNAi-Show -1.0
BAF53-Related -1.0
RNAi-GATA2 -1.0
Pathways-PC9 0.0
TET2-studies -1.0
Tumors-Represent -1.0
Promote-Endodermal -1.0
Comparison-LABORATORY -1.0
Epigenetic-EVENTS -1.0
Difference stage-Carcinoma, Embryonal -1.0
Proteasome-Enhance -1.0
Activated-Oncogens -1.0
Development-TUMORIGENICITY -1.0
-- Prostate Cancer-overexpress 0.0
miRNA-RNA 0.3333
derivatives-Tumor cells -1.0
Production-Mutations -1.0
Myeloid Differentiation-commitment -1.0
strategies-Result -1.0
Leukemic Cells-Promoter -1.0
Represent-Normal cell division -1.0
Thought-TUMOR -1.0
RAS-Result -1.0
cancer cells-CELL -1.0
NSCLC-Non-Small Cell Lung Cancer 1.0
Cells-Mutation 0.1429
Centrosomes-Interphase 0.0667
caspase activity-ABLATION -1.0
Entry-studies -1.0
Mutations-Development -1.0
IDH-IDH2 -1.0
Phosphorylation-Box -1.0
Phosphorylation Site-APC -1.0
Tumor Suppressor-BREAST -1.0
Mutant-striking -1.0
Agent-Kinase -1.0
ACUTE MYELOGENOUS LEUKEMIA-TET2 -1.0
Human cells-Reports -1.0
Mutant-Researchers -1.0
Actin-Regulated -1.0
G2/M Arrest-CERVICAL CANCER -1.0
mir-223-ATRA -1.0
Cell Cycle Arrest-Fibroblasts -1.0
WT1-Permit -1.0
Repression-Genesis -1.0
Mitosis-Homologous -1.0
Occur-EVENTS -1.0
Genes-Drive 0.0909
model-RAS -1.0
IDH2 Mutation-ENZYMES -1.0
NSCLC-PC9 0.0
Thought-Retinoblastoma -1.0
Oct-4-MICROARRAY -1.0
PC9-Aurora-A 0.0
GATA2-Responsible -1.0
PC9-Tumorigenesis 0.0
IDH2 Gene-Transformation -1.0
Process-Researchers -1.0
Process-Cancer -1.0
Aurora-A kinase-Cell Proliferation 0.0833
Aurora-A-Cell Proliferation -1.0
AN-Tumor Suppressor Proteins 0.1
Tumors-STANDING -1.0
Human-play -1.0
Electroporation-VARIOUS -1.0
cancer screen-Protein A -1.0
Ectodermal-Chromatin Structure -1.0
Tumor Suppressor Proteins-E2F-1 -1.0
TET2-Block -1.0
TRANSCRIPTION FACTOR-TRAF6 0.1667
-- Leukemia-Carcinoma, Thyroid 0.0
Transcription Factors-Granulopoiesis -1.0
Actin-Related -1.0
Cells-Result -1.0
Differentiated-studies -1.0
Cell Cycle Progression-Deletion -1.0
FUNCTIONS OF REPRODUCTION-CELL -1.0
therapeutics-Block -1.0
Ionising radiation-APC -1.0
Progression-research results -1.0
IDH2 Mutation-Inhibiting -1.0
Epigenetic Change-Phenomena -1.0
EGFR-Process -1.0
SWI-ATP-dependent chromatin remodeling -1.0
Mutant-Mice -1.0
Tumor cells-Signaling Molecule -1.0
-- Leukemia-Reports 0.0
IDH1 Mutation-IDH1 -1.0
Cell Cycle Progression-Kinase -1.0
Ubiquitination-Study -1.0
Fibroblasts-RAS Oncogene -1.0
bcl-xL-Tumor cells -1.0
Genes-TREAT -1.0
Transcriptional Networks-SEQUENCING -1.0
Pathways-HOPX -1.0
cancer screen-Mutation -1.0
Ubiquitination-degradation of cyclin -1.0
Mouse, NOS-bind -1.0
RIP3-Show -1.0
bcl-xL-Result -1.0
IL1-Ionising radiation -1.0
Ubiquitination-Skin 0.0909
Study-Anaphase Promoting Complex -1.0
Normal cell division-cumulative gene -1.0
Crassa-Deletion -1.0
pRB-Cancer -1.0
roscovitine-Work -1.0
Drive-PC9 0.0
ES-Study -1.0
Tumor cells-Hallmark Cell -1.0
virus infection-Chemical -1.0
Epigenetic-TISSUE -1.0
Mutations-c-Raf -1.0
Occur-Development -1.0
ESC-cells differentiation -1.0
model-GATA2 Transcription Factor -1.0
ABT-737-FAMILY MEMBER -1.0
ES-Plasmid 0.125
IDH2 Mutation-IDH -1.0
cancer screen-Defined -1.0
Chromatin-Complexes -1.0
Tumors-Process -1.0
EGFR-localisation -1.0
Phosphorylation Site-Proteolytic -1.0
G1 Arrest-Reported -1.0
TET2-Metabolite -1.0
Activated-Alone -1.0
play-Exhibit -1.0
TET1-Tet -1.0
Tissues-Maturation -1.0
NSCLC-KRAS -1.0
Identified-Pancreatic Cancer -1.0
Proteasome-Promoter -1.0
CAAT-Enhancer Binding Protein-Feedback 0.0909
Show-Human -1.0
GATA2-Viability, Cell -1.0
Anaphase-Homolog -1.0
human cell lines-Show -1.0
Reported-Mutations -1.0
Breast Cancer--- Leukemia 0.0
IDH1-Inhibiting -1.0
Process-Tumor Progression -1.0
Cell Lines-Drive 0.1111
GATA2-Pathways -1.0
Cancer-NSCLC -1.0
Aurora-A-Cell Growth -1.0
Tumor regression-Very Important -1.0
Show-serine/threonine-protein kinase -1.0
miRNA-IRS-1 -1.0
PPP-Models -1.0
Murine-Embryonic Stem Cells -1.0
Branch-KRAS -1.0
BAF53-VARIOUS -1.0
mir-223-Line -1.0
Cancer-INTERMEDIATE -1.0
Production-IDH -1.0
derivatives-Cytotoxic -1.0
bcl-xL-Block -1.0
Identified-Responsible -1.0
P53-E2F-1 -1.0
TBK1-Defined -1.0
mir-223-Roles -1.0
MCF-SDS PAGE -1.0
Breast Cancer-Relapsing -1.0
metastasis--- Lung Cancer 0.0
cancer cells-Binding -1.0
CERVICAL CANCER-Pancreatic Cancer 0.3333
Immortalized-Signaling Molecule -1.0
studies-Tumors -1.0
UP-Detected -1.0
GATA2-centrosomin -1.0
telomerase activity-AKT -1.0
Selection-Normal cell division -1.0
signalling-Anaphase Promoting Complex -1.0
studies-cervical cancers -1.0
Cancer-Drive -1.0
Inhibition-Tumor cells -1.0
bcl-xL-Permit -1.0
Resistance-Reported -1.0
strategies-Defined -1.0
GATA2-Related -1.0
GATA2-Activities -1.0
studies-Carcinoma, Embryonal -1.0
Crassa-Kinase -1.0
Relapsing-IRS-1 -1.0
TREAT-Cell Growth -1.0
TRANSCRIPTION FACTOR-bind -1.0
Ubiquitination-Box -1.0
DNA hypermethylation-Promoter -1.0
TET2-Leukemic Cells -1.0
Cancer-Cell metabolism -1.0
Pitta-used -1.0
TAK1-Result -1.0
Oncogene-BREAST 0.0833
NSCLC-degradation of cyclin -1.0
GATA2-Agent -1.0
Drive-Ionising radiation -1.0
Flow-Lethal -1.0
Proteasome-Anaphase Promoting Complex 0.1429
Genes-Regulated -1.0
ABT-737-apoptotic cell death -1.0
derivatives-Reported -1.0
hTERT-INTERMEDIATE -1.0
Proliferative-P53 -1.0
ABLATION-TRAF6 -1.0
localisation-Phosphorylation -1.0
P53-Mammalian Cell -1.0
NSCLC-RNAi -1.0
GATA2-look -1.0
localisation-Aurora-A kinase -1.0
Electroporation-Analyzed -1.0
Epigenetic-Thought -1.0
EVENTS-Cell metabolism -1.0
Trigger-Mammalian Cell -1.0
mediated-Fibroblasts -1.0
Senescence-Like -1.0
GATA6-Aurora-A -1.0
-- Prostate Cancer-P53 0.0
Occur-Epigenetic Change -1.0
Telophase-localisation -1.0
Leukemic Cells-Block -1.0
Growth arrest-RAS -1.0
Transcripts-Companions -1.0
cancer cells-PROTEIN -1.0
Cell types-Researchers -1.0
Activated-RAS -1.0
miRNAs-Myelopoiesis 0.0769
Mesodermal-Pluripotent Stem Cell -1.0
IDH-IDH1 Mutation -1.0
TET2-Tumors -1.0
Carbon-AS gene -1.0
20%-Synthetic -1.0
Differentiated-Embryonal Carcinoma Cell -1.0
WT1-Pathway -1.0
Drug Resistance-study use -1.0
Cells-Process -1.0
Trigger-Genotoxic Stresses -1.0
LATS2-Block -1.0
Oncogene-Neural Tumors -1.0
Tumor Suppressor-Suppressor -1.0
Human-PLK1 -1.0
cancer cells-Anaphase Promoting Complex -1.0
Granulopoiesis-miRNAs -1.0
WAS-Human cells -1.0
Cell Growth-Functional Component -1.0
pRB-Genesis -1.0
Haematopoiesis-Myelopoiesis 0.3333
Mutant-Tumor cells -1.0
LEAD-research results -1.0
CERVICAL CANCER-Carcinoma, Thyroid 0.3333
System-Cell Differentiation -1.0
Aurora-A kinase-Block -1.0
Adopted-Cells -1.0
P53-LEAD 0.0833
GATA2-Permit -1.0
Promote-Maintain -1.0
GATA2-Cells -1.0
studies-depend -1.0
Flow-LABORATORY -1.0
GATA2-LUNG TUMOR -1.0
AML-IDH2 Mutation -1.0
WAS-Exhibit -1.0
CAAT-Enhancer Binding Protein-CCAAT Enhancer Binding Protein 1.0
DNA hypermethylation-2-HG -1.0
Leukemic Cells-IDH1 Gene Mutation -1.0
Activated-Tumor Suppressor -1.0
STANDING-research data -1.0
Oct-4-Differentiation -1.0
IDH2 Gene-Clarified -1.0
Primitive-Stem Cells -1.0
Show-localisation -1.0
Related-NSCLC -1.0
localisation-LATS2 -1.0
Oct-4-Endodermal -1.0
Mutations-NSCLC 0.0909
EVENTS-Cell Growth -1.0
mir-223-Study -1.0
Epigenetic-cumulative gene -1.0
Show-Myelopoiesis -1.0
Mutations-Drive 0.1111
Tumor regression-research results -1.0
Mouse, NOS-Cells -1.0
Related-Drive -1.0
Retinoblastoma Protein-Tumors 0.125
Branch-GATA2 -1.0
Mice-EGFR -1.0
Relapsing-Show -1.0
STK33-Mutation -1.0
fight-Process -1.0
Tumor Suppressor Proteins-Proteolysis 0.1
KRAS-Tumor cells -1.0
Mutant-Defined -1.0
kill-Protein A -1.0
Differentiation-VARIOUS -1.0
Mutations-IDH1 Mutation -1.0
Drug Resistance-Treated with -1.0
Mutations-Lead 2+ 0.0
metastasis-HEPATOCELLULAR CARCINOMA 0.25
mir-223-Promoter -1.0
Expression Profiling-Cell types -1.0
Centrosomes-Oncogens 0.0667
Nucleotides-Translational -1.0
Pathway-Individual -1.0
Plays-LATS2 -1.0
cancer cells-Response -1.0
Centrosomes-Detected -1.0
P53-pRB -1.0
GATA2-Result -1.0
Detected-Aurora-A -1.0
study use-DATA SET -1.0
hTERT-serine/threonine-protein kinase -1.0
Cell Cycle Progression-Affect -1.0
metastasis-Head 0.1667
Cyclin-D1-studies -1.0
Human-Roles 0.0588
Pancreatic Cancer-P53 0.1667
Plays-LATS1 -1.0
localisation-Plays -1.0
mir-223-Transcription Factors -1.0
mir-223-Cell Differentiation -1.0
Differentiated-MICROARRAY -1.0
NSCLC-Ionising radiation -1.0
EVENTS-AKT -1.0
G1 Arrest-Genotoxic Stresses -1.0
Micro-tubule-Oncogens -1.0
TET2-IDH2 Gene -1.0
LEAD-Maintain -1.0
Tumors-Normal cell division -1.0
RIP-Reported -1.0
Tumor Suppressor-Malignant -1.0
Cyclin-D1-Genotoxic Stresses -1.0
Mutant--- Lung Cancer 0.0
Leukemic Cells-IDH1 Mutation -1.0
Identified-degradation of cyclin -1.0
Cells-Development -1.0
Identified-Mice -1.0
Adenocarcinoma of the Lung-Oncogens -1.0
MCF-Western Blotting -1.0
Fibroblasts-Gene Expression 0.1111
caspase activity-necrotic cell death -1.0
play-Retinoblastoma -1.0
TAK1-Defined -1.0
combinations-degradation of cyclin -1.0
TET1-Transformation -1.0
Researchers-GATA2 -1.0
Researchers-GATA6 -1.0
Chemical-ABLATION -1.0
Human-Reports -1.0
mir-223-miRNAs -1.0
GATA2-bind -1.0
Crassa-Anaphase -1.0
Endodermal-tumor growth -1.0
Primitive-Maintain -1.0
mir-223-Mouse, NOS -1.0
IDH-2-HG -1.0
Transcriptional Network-Ionising radiation -1.0
PPP-Lethal 0.1429
Mutant-RNAi -1.0
Breast Cancer-CHRONIC LYMPHOCYTIC LEUKEMIA 0.3333
Mice-Cells 0.0769
Human-Renilla 0.0769
Epigenetic-Normal cell division -1.0
TET2-Redundant -1.0
Differentiated-VARIOUS -1.0
Identified-Pathway -1.0
studies-Regulation -1.0
Mitosis-Cell Cycle 0.25
G2/M Arrest-Regulated -1.0
Activated-Oncogenes -1.0
KRAS-Mutation -1.0
NIH 3T3 Cells-TERM -1.0
Differentiation-Carcinoma, Embryonal -1.0
Represent-TUMORIGENICITY -1.0
Phosphorylation-Phosphorylation Site -1.0
Mouse, NOS-Reagent -1.0
Human-Repression 0.0625
Fibroblasts-Oncogens 0.1
Myeloid Differentiation-Differentiation -1.0
Aurora-A-MIR-21 -1.0
Micro-tubule-Work -1.0
roscovitine-resistance Determinant -1.0
EC Cell-Reports -1.0
KRAS-EGFR -1.0
Tissues-Roles 0.125
Take-Hallmark Cell -1.0
Pathway-Tumor specimens -1.0
Oct-4-Pluripotent Stem Cell -1.0
Advance-Drug Discovery -1.0
EC Cell-TUMOR TISSUE -1.0
Human cells-Repression -1.0
neoplastic transformation-cumulative gene -1.0
caspase activity-Caspase Inhibitors -1.0
Human-Lesion -1.0
RIP3-Motif -1.0
Take-Box -1.0
EVENTS-serine/threonine-protein kinase -1.0
Tumor Suppressor-Human cells -1.0
Ectodermal-Maintain -1.0
miRNA-LYMPHOMA 0.1111
shRNA-studies -1.0
Drug Resistance-NSCLC 0.0909
shRNA-used -1.0
Tissues-CDK5RAP2 -1.0
Identified-Regulated -1.0
Micro-tubule-Cell Lines -1.0
Rest-Small Cell Lung Cancers -1.0
-- Leukemia-Cervical Squamous Cell Carcinoma 0.0
Tumor regression-Advance -1.0
Transcriptional Network-degradation of cyclin -1.0
Regression-FAMILY MEMBER -1.0
Transcriptional Networks-Transfection 0.125
Occur-Epigenetic -1.0
metastasis-Clear cell Kidney Cancer -1.0
RIP3-Reported -1.0
TBK1-depend -1.0
CCAAT Enhancer Binding Protein-Study -1.0
OVARIAN CANCER-CYCLIN E 0.1
EC Cell-Study -1.0
20%-Lethal -1.0
Human-Study -1.0
Expression Profiling-VARIOUS -1.0
Chemical-Process -1.0
ESC-Companions -1.0
Transcriptional Networks-TUMOR TISSUE -1.0
Binding-Related -1.0
Cell Lines-AS gene -1.0
Phosphorylation-Block -1.0
Transcriptional Networks-Study -1.0
EGFR-LATS -1.0
Human-Tumor Suppressor Proteins 0.0588
GATA6-localisation -1.0
Myelopoiesis-specific -1.0
Show-Affect -1.0
Cell Growth-NDEL1 -1.0
Myeloid Differentiation-LED -1.0
Reported-Survey -1.0
Mammalian-ATP-dependent chromatin remodeling -1.0
Human gene-Show -1.0
these-Tumors -1.0
TET2-2-HG -1.0
lung tumors-Cells -1.0
Mouse, NOS-Point A -1.0
System-ATRA -1.0
Flow-Drive -1.0
RNA Interference-Defined -1.0
Immortalized-Cell Survival -1.0
Researchers-Cell Growth -1.0
Drug Resistance-BORTEZOMIB -1.0
Cells-Lethal 0.1111
LEAD-Advance -1.0
Interest-GATA2 Transcription Factor -1.0
AN-Proteolysis 0.1111
Trigger-Activate -1.0
Cell Cycle Progression-Examined -1.0
Development-EVENTS -1.0
Mammalian Cell-Proteolysis -1.0
Electroporation-HeLa Cells 0.1111
TET2-used -1.0
IDH1 Mutation-Genomic -1.0
MDM2-Growth arrest -1.0
Tumor regression-LUNG TUMOR -1.0
Progression-fight -1.0
Account #-Models 0.0
mir-223-NF1 -1.0
Occur-Phenotype -1.0
Mice-Human 0.1
EC Cell-Transfection -1.0
Entry-Cell Proliferation -1.0
apoptotic cell death-FAMILY MEMBER -1.0
Chemical-Show -1.0
Oct-4-Expression Profiling -1.0
Occur-Represent -1.0
Growth arrest-NIH 3T3 Cells -1.0
Reported-IDH2 Mutation -1.0
IDH1 Mutation-Study -1.0
Production-Leukemic Cells -1.0
Electroporation-Protein Expression -1.0
Transcriptional Networks-qRT-PCR -1.0
GATA2-Kinase -1.0
miRNA-Head 0.1111
LATS2-Anaplastic Thyroid Cancer -1.0
Researchers-Cells 0.1667
Adenocarcinoma of the Lung-TRAF6 -1.0
compromise-Death Receptors -1.0
LEAD-Promoter -1.0
Either-Fulfill -1.0
pRB-Ubiquitin -1.0
pRB-INK4a -1.0
Oct-4-Transcript -1.0
Bcl-2-Cytotoxic -1.0
metastasis-Pancreatic Cancer 0.25
Cancer-ligase inhibitor -1.0
Response-Absence -1.0
Aurora-A kinase-Aurora-A -1.0
Entry-cervical cells -1.0
Reported-Metabolite -1.0
pRB-Retinoblastoma -1.0
GATA2-RAS -1.0
Comprise-Granulopoiesis -1.0
model-Oncogens -1.0
-- Prostate Cancer-CYCLIN E 0.0
TET2-Carrying -1.0
Cell Lines-LABORATORY 0.1111
CERVICAL CANCER-miRNA 0.1111
Proteasome-Oncogens 0.1111
Proteolysis-Growth arrest -1.0
Roles-Granulocyte 0.1
Take-THREONINE -1.0
Reported-Functional Component -1.0
IDH2 Gene-Contribute -1.0
Identified-CHRONIC LYMPHOCYTIC LEUKEMIA -1.0
IDH2 Gene-Show -1.0
Take-Cell Survival -1.0
Growth arrest-Cells -1.0
AN-E2F-1 -1.0
Oct-4-Companions -1.0
localisation-Human -1.0
IDH1 Mutation-Scale -1.0
LATS2-Show -1.0
Production-DNA hypermethylation -1.0
virus infection-DEATH -1.0
therapeutics-Reported -1.0
miRNA-Oncogene 0.0714
Progenitor Cell proliferation-commitment -1.0
Kinase-Homolog -1.0
Phosphorylation-MIR-21 -1.0
Phosphorylation Site-Skin -1.0
apoptotic cell death-Reported -1.0
TET2-Show -1.0
G1 Arrest-APC -1.0
State-Cell Growth -1.0
Mutations-cervical cancers -1.0
Oct-4-Plays -1.0
Ras proteins-Gene Expression 0.0909
inhibitors-necrotic cell death -1.0
inhibitors-Cell Growth -1.0
Tumors-TISSUE 0.2
STANDING-Drug Discovery -1.0
mediated-Rodent -1.0
P53-ligase inhibitor -1.0
Reported-IDH1 -1.0
Reported-IDH2 -1.0
Phosphorylation-CDK5RAP2 -1.0
GATA2-PC9 0.0
Cyclin-Dependent Kinase Inhibitor-resistance Determinant -1.0
RNA Interference-Protein A 0.0769
Mammalian Cell-Genotoxic Stresses -1.0
Tumor regression-fight -1.0
mek-inhibitors -1.0
ENZYMES-Regulation -1.0
Progenitor Cell proliferation-LED -1.0
Reported-resistance Determinant -1.0
Regulation-All-trans Retinoic Acid -1.0
CCAAT Enhancer Binding Protein-miRNA 0.1111
Fibroblasts-Cultured Cells 0.25
strategies-inhibitors -1.0
TRANSCRIPTION FACTOR-Development -1.0
Murine-VARIOUS -1.0
Phosphorylation-Cell Proliferation 0.125
studies-VARIOUS -1.0
GATA2-GATA2 Transcription Factor -1.0
Affect-localisation -1.0
SWI-VARIOUS -1.0
play-Genesis -1.0
KRAS-Drive -1.0
inhibitors-GATA6 -1.0
mediated-Senescence -1.0
Reported-Process -1.0
Occur-Redundant -1.0
MIR-21-Genes -1.0
Reported-Anaplastic Thyroid Cancer -1.0
Show-THREONINE -1.0
Mutant-Permit -1.0
TET2-mediated -1.0
HeLa-Analyzed -1.0
solid tumors-Reported -1.0
Drive-Very Important -1.0
Represent-Process -1.0
Ionising radiation-Mammalian Cell -1.0
Human cells-Up-Regulation -1.0
Drive-GATA6 -1.0
Resistance-Cytotoxic -1.0
Mesodermal-Maintain -1.0
Tumor cells-Drive -1.0
TREAT-depend -1.0
miRNAs-Granulocyte 0.1
Tumor regression-Promoter -1.0
Occur-Selection -1.0
G1 Arrest-Mammalian Cell -1.0
G2/M Arrest-Papillary Thyroid Carcinoma -1.0
CERVICAL CANCER-IRS-1 -1.0
Breast Cancer--- Lung Cancer 0.0
GATA2-LATS -1.0
GATA2-GTP -1.0
Necrotic-Caspase Inhibitors -1.0
KRAS G12D-KRAS -1.0
Show-Homolog -1.0
FUNCTIONS OF REPRODUCTION-NH2 -1.0
Tumor regression-Development -1.0
CERVICAL CANCER-Show -1.0
CERVICAL CANCER-Maturation -1.0
study use-Carcinoma, Embryonal -1.0
Phosphorylation-Cell Cycle 0.1429
Tumor cells-INTERMEDIATE -1.0
Cell Cycle Progression-localisation -1.0
Endodermal-Maintain -1.0
ABT-737-Resistance -1.0
Cells-Show -1.0
WAS-Genesis -1.0
Phosphorylation-Maturation -1.0
shRNA-LED -1.0
LEAD-Chromatin Structure -1.0
Relapsing-Pancreatic Cancer -1.0
Drive-EGFR -1.0
Human cells-CO -1.0
Rest-Human cells -1.0
Necrotic-kinase activity -1.0
studies-Permit -1.0
in vitro study-LED -1.0
Binding-ATP-dependent chromatin remodeling -1.0
IDH-Metabolite -1.0
Human-CO 0.0625
Cell Growth-Tumorigenesis -1.0
Carbon-Synthetic -1.0
Papillary Carcinoma of the Thyroid-Stimulated -1.0
bcl-xL-Pathway -1.0
strategies-Sequence -1.0
Tumor Suppressor Proteins-ligase inhibitor -1.0
Breast Cancer-Breast Cancer Cell -1.0
lung tumors-LOX -1.0
Tumor regression-Enhance -1.0
Development-P53 -1.0
Oct-4-CO -1.0
P53-Genotoxic Stresses -1.0
Phosphorylation-Cyclin-D1 -1.0
Human-ACT -1.0
Drug Resistance-Patients 0.125
Host Defense-DEATH -1.0
necroptosis-Necrotic -1.0
NSCLC-Either -1.0
look-striking -1.0
Mice-HOPX -1.0
Response-LATS2 -1.0
Relapsing-Carcinoma, Thyroid -1.0
Cell Cycle Arrest-INK4a -1.0
CERVICAL CANCER-Identified -1.0
Tumor cells-AKT -1.0
BE-Examined -1.0
EC Cell-SEQUENCING -1.0
metastasis-INSULIN RECEPTOR SUBSTRATE 1 -1.0
Human-RB1 0.0588
Micro-tubule-Promote -1.0
Account #-LABORATORY 0.0
IDH1 Mutation-Redundant -1.0
TREAT-Defined -1.0
GATA2-Checkpoint -1.0
-- Prostate Cancer-LATS2 0.0
mediated-Growth arrest -1.0
-- Lung Cancer-research data 0.0
Roles-Show -1.0
FUNCTIONS OF REPRODUCTION-Binding -1.0
Haematopoiesis-Human Development 0.1111
Kinase-play -1.0
TAK1-depend -1.0
lung tumors-GATA2 -1.0
NSCLC-Reported -1.0
Fibroblasts-Tumor Suppressor -1.0
Adopted-Cell Differentiation -1.0
studies-inhibitors -1.0
miRNA-Breast Cancer Cell -1.0
TBK1-Result -1.0
pRB-Exhibit -1.0
anti-apoptosis-Work -1.0
Block-RAS -1.0
Papillary Carcinoma of the Thyroid-overexpress -1.0
Reported-Checkpoint -1.0
Study-degradation of cyclin -1.0
Reported-IDH -1.0
Binding-PROTEINS -1.0
Drive-research results -1.0
Mcl-1-resistance Determinant -1.0
Crassa-N NOS -1.0
Affect-Homolog -1.0
Researchers-Fulfill -1.0
HeLa-HeLa Cells -1.0
Motif-Reported -1.0
Host Defense-Necrotic -1.0
Tumors-Inhibiting -1.0
Human-90% -1.0
Electroporation-SDS PAGE -1.0
TET2-Lanugo -1.0
play-RB1 -1.0
hTERT-Signaling Molecule -1.0
Related-TREAT -1.0
Carrying-Show -1.0
Clarify-Myelopoiesis -1.0
Telophase-Consideration -1.0
Oct-4-ANALYSIS -1.0
roscovitine-Model System -1.0
pRB-Senescence -1.0
Regression-Cytotoxic -1.0
FUNCTIONS OF REPRODUCTION-Cyclin-D1 -1.0
Mcl-1-Model System -1.0
Tumors-research results -1.0
KRAS-HOPX -1.0
Roles-Cell Cycle 0.1
Production-Promoter -1.0
Micro-tubule-miRNA -1.0
Mcl-1-Lanugo -1.0
Cell types-Scientific -1.0
Tumors-Epigenetic -1.0
Differentiation-POU5F1 -1.0
Granulopoiesis-System -1.0
Cyclin-Dependent Kinases-RAS -1.0
Show-Human Development -1.0
ESC-Transcripts -1.0
Drive-Cell Growth -1.0
Rest-Oncogene 0.0714
Reported-Activities -1.0
Mammalian-PROTEINS -1.0
play-90% -1.0
Chips-Embryoid Bodies -1.0
signalling-D1 -1.0
Tumors--- Lung Cancer 0.0
Affect-N NOS -1.0
RNA Interference-inhibitors -1.0
Affect-Consideration -1.0
NSCLC-human cell lines -1.0
Epigenetic Change-Development -1.0
research results-research data -1.0
CERVICAL CANCER-CDK5RAP2 -1.0
shRNA-commitment -1.0
Translational Repression-RNA -1.0
Oct-4-Transcripts -1.0
TISSUE-cumulative gene -1.0
Selection-Development -1.0
P53-Fibroblasts 0.0909
Occur-Survey -1.0
System-All-trans Retinoic Acid -1.0
Activate-Proteolysis -1.0
Progenitor-Maintain -1.0
Chemical-kinase activity -1.0
Progression-N NOS -1.0
Phosphorylation Site-Study -1.0
State-Cell Proliferation -1.0
Growth arrest-Result -1.0
Examined-N NOS -1.0
IDH1-IDH -1.0
Growth arrest-Oncogenes -1.0
Tumor regression-Oncogens -1.0
Cyclin-Dependent Kinase Inhibitor-ABT-737 -1.0
Phosphorylation-APC 0.1111
Tumors-fight -1.0
Pathways-Reported -1.0
Chemical-RIPK3 -1.0
HeLa-Protein Expression -1.0
Chemical-RIPK1 -1.0
Entry-Promote -1.0
Roles-LATS1 -1.0
Mutant-Agent -1.0
pRB-Gene Mutation -1.0
EC Cell-qRT-PCR -1.0
P53-studies -1.0
localisation-PLK1 -1.0
Promote-Ectodermal -1.0
telomerase activity-Cell metabolism -1.0
Human cells-Transfection -1.0
Cells-Checkpoint -1.0
Tumor cells-NSCLC -1.0
Oct-4-VARIOUS -1.0
ABLATION-GATA2 Transcription Factor -1.0
TREAT-Viability, Cell -1.0
mir-223-Myelopoiesis -1.0
Mcl-1-PROTEIN -1.0
Host Defense-caspase activity -1.0
Cancer-Proteolysis -1.0
Tumors-neoplastic transformation -1.0
GATA2-Protein A -1.0
Related-Pathways -1.0
PC9-NDEL1 0.0
Tumors-Individual -1.0
Senescence-Alone -1.0
Granulopoiesis-ANIMAL -1.0
telomerase activity-Cell Growth -1.0
Comparison-Lethal -1.0
GATA2-Functional Component -1.0
Mcl-1-Cyclin-Dependent Kinase Inhibitor -1.0
OVARIAN CANCER-P53 0.1667
Oct-4-Renilla -1.0
inhibitors-Caspase 8 gene -1.0
telomerase activity-Hallmark Cell -1.0
TET2 Gene-Study -1.0
KRAS-TREAT -1.0
Entry-Cancer -1.0
studies-Embryonic Stem Cells -1.0
look-GTP -1.0
Micro-tubule-Cell Proliferation -1.0
signalling-Ionising radiation -1.0
Mouse, NOS-UTR -1.0
Breast Cancer-Tumors 0.5
KRAS-Defined -1.0
GATA2-Anaphase Promoting Complex -1.0
Cells-Phenomena -1.0
Take-Skin -1.0
Trigger-APC -1.0
Catalytic-IDH1 Gene Mutation -1.0
Interest-RAS -1.0
strategies-Mutation -1.0
Pancreatic Cancer-LATS2 -1.0
DNA hypermethylation-Enzymatic Activity -1.0
Bcl-2-solid tumors -1.0
NIH 3T3 Cells-Result -1.0
RIP1-RIP 1.0
ANALYSIS-Embryoid Bodies 0.1
TISSUE-EVENTS -1.0
MDM2-Fibroblasts -1.0
Myeloid Differentiation-studies -1.0
Development-CYCLIN E -1.0
Genes-Transcripts -1.0
FUNCTIONS OF REPRODUCTION-Stress -1.0
Reported-Tumors -1.0
TRAF6-Sporadic -1.0
Aurora-A kinase-Maturation -1.0
ACUTE MYELOGENOUS LEUKEMIA-TET2 Gene -1.0
Show-specific -1.0
Primitive-tumor growth -1.0
Tumor Suppressor Proteins-TUMOR 0.125
AML-Clarified -1.0
UP-Tissues -1.0
TET2-IDH1 Gene Mutation -1.0
signalling-Responsible -1.0
KRAS-Either -1.0
MICROARRAY-cells differentiation -1.0
solid tumors-FAMILY MEMBER -1.0
Cell Cycle Arrest-Rodent -1.0
SWI-PROTEINS -1.0
Mouse, NOS-Microarray Analysis -1.0
Identified-Clear cell Kidney Cancer -1.0
Haematopoiesis-Show -1.0
Wild Type-inhibitors -1.0
Phosphorylation-PLK1 -1.0
Breast Cancer-LATS2 -1.0
Plays-Maturation -1.0
Mice-Viability, Cell 0.0667
CERVICAL CANCER-Regulation -1.0
Transcriptional Networks-Point A -1.0
Promote-Stem Cells -1.0
Mutations-IDH1 Gene Mutation -1.0
TAK1-Tumor cells -1.0
Show-D1 -1.0
Lethal-GTP 0.0769
inhibitors-Process -1.0
Regulated-ATP-dependent chromatin remodeling -1.0
RIP3-Homologous Sequences -1.0
IDH-Promoter -1.0
Account #-Drive 0.0
Tumorigenesis-studies -1.0
Tet-Regulation -1.0
miRNA-Reports -1.0
Breast Cancer-Cervical Squamous Cell Carcinoma -1.0
Proteolysis-RAS -1.0
strategies-Permit -1.0
model-Promoter -1.0
KRAS-Researchers -1.0
LEAD-Oncogens 0.1111
Necrotic-ABLATION -1.0
-- Leukemia--- Lung Cancer 0.0
Human cells-TUMOR TISSUE -1.0
Breast Cancer-Show -1.0
Cells-Activities -1.0
PPP-AS gene -1.0
HeLa-SDS PAGE -1.0
Show-Kinase -1.0
GATA2-Tumorigenesis -1.0
Cultured Cells-Cell Cycle 0.125
virus infection-inhibitors -1.0
Nuclear Matrix-VARIOUS -1.0
Actin-SWI -1.0
Myelopoiesis-Characterized -1.0
IDH2 Gene-Genomic -1.0
Transcriptional Networks-Reagent -1.0
Promote-Differentiation -1.0
STK33-Tumor cells -1.0
Roles-Homologous -1.0
KRAS G12D-Drive -1.0
Cyclin-D1-Skin -1.0
Mutant-Show -1.0
Drive-Cells 0.1429
bcl-xL-inhibitors -1.0
IDH1 Mutation-Show -1.0
Inhibition-Mutation 0.1111
ABLATION-Enhance -1.0
Branch-AS gene -1.0
Crassa-Progression -1.0
roscovitine-ABT-737 -1.0
Cancer-Cell Growth -1.0
WAS-Gene Mutation -1.0
inhibitors-Viability, Cell -1.0
in vitro study-Differentiation -1.0
Represent-Excite -1.0
Tissues-E2F-1 -1.0
EGFR-Show -1.0
Regulation-Regulated -1.0
Mutant-Kinase -1.0
Human-SEQUENCING -1.0
PROTEIN-ACUTE MYELOGENOUS LEUKEMIA -1.0
STK33-Protein A -1.0
GATA2-Mutation -1.0
BAF53-Complexes -1.0
KRAS-Reported -1.0
STANDING-Excite -1.0
P53-Tissues 0.1111
Occur-Mutations -1.0
TET2-Clarified -1.0
Cells-NDEL1 -1.0
cRaf-Drive -1.0
Take-Signaling Molecule -1.0
AN-Cancer -1.0
State-MIR-145 -1.0
KRAS-Fulfill -1.0
STK33-Permit -1.0
Caco-2 Cells-VARIOUS -1.0
Identified-Carcinoma, Thyroid -1.0
Mesodermal-Transcript -1.0
Malignant-Advance -1.0
Senescence-Activated -1.0
Ectodermal-Pluripotent Stem Cell -1.0
regulation of ribosome biogenesis-E2F-1 -1.0
RIP3-RIP -1.0
Micro-tubule-cervical cells -1.0
Cancer-Immortalized -1.0
Tumor regression-GATA2 Transcription Factor -1.0
TISSUE-Phenotype 0.1667
Regulation-LATS2 -1.0
model-Development -1.0
localisation-CDK5RAP2 -1.0
Identified-Oncogene -1.0
Signaling Pathways-TREAT -1.0
Activate-Genotoxic Stresses -1.0
Phosphorylation-LATS2 -1.0
Examined-Wild Type -1.0
Phosphorylation-LATS1 -1.0
Viability, Cell-LATS 0.0769
UP-Regulation -1.0
MCF-VARIOUS -1.0
Reported-Work -1.0
EGFR-Functional Component -1.0
Malignant-STANDING -1.0
Cyclin-D1-D1 -1.0
Report-Cell Growth -1.0
Represent-cumulative gene -1.0
KRAS-Mice -1.0
Viability, Cell-Functional Component -1.0
Progenitor-POU5F1 -1.0
Lethal-Result -1.0
Proteasome-TRAF6 0.0909
Mcl-1-bcl-xL -1.0
Embryonal Carcinoma Cell-Cell types -1.0
KRAS-Library -1.0
Viability, Cell-centrosomin -1.0
GATA6-Activities -1.0
Aurora-A kinase-CDK5RAP2 -1.0
Examined-localisation -1.0
DNA hypermethylation-IDH1 Gene Mutation -1.0
Take-Study -1.0
Report-Block -1.0
shRNA-Lanugo -1.0
Related-Researchers -1.0
WT1-inhibitors -1.0
Expression Profiling-cells differentiation -1.0
GATA2-Cell Growth -1.0
Mutation-Result -1.0
Human Development-Mouse, NOS -1.0
used-Screen -1.0
Production-Phenotype -1.0
HOPX-Functional Component -1.0
CERVICAL CANCER-Stimulated -1.0
Catalytic-Carrying -1.0
Activated-Cellular Stress Response -1.0
Tumor Suppressor Proteins-P14 -1.0
Tumor Suppressor Proteins-P19 -1.0
Mouse, NOS-TUMOR TISSUE -1.0
Represent-Drug Discovery -1.0
Regulated-Transcripts -1.0
compromise-RIPK1 -1.0
compromise-RIPK3 -1.0
P53-Genotoxic Stress -1.0
Oct-4-study use -1.0
Adopted-Study -1.0
Activated-Result -1.0
Alone-research results -1.0
Promote-Pluripotent Stem Cell -1.0
APC-Proteolysis 0.1111
Drive--- Lung Cancer 0.0
Cancer-Gene Mutation -1.0
Tissues-MDM2 -1.0
Proteolysis-Fibroblasts 0.1111
Computational-MIR-21 -1.0
Show-Mice -1.0
DNA hypermethylation-Phenotype -1.0
Ectodermal-POU5F1 -1.0
lung tumors-virus -1.0
MICROARRAY-Carcinoma, Embryonal -1.0
20%-AS gene -1.0
studies-Contribute -1.0
Expression Profiling-DATA SET -1.0
Oct-4-TUMOR TISSUE -1.0
Primitive-Pluripotent Stem Cell -1.0
Progression-play -1.0
TREAT-EGFR -1.0
Block-Fibroblasts -1.0
Ubiquitination-APC 0.1
DEATH-necrotic cell death -1.0
Chromatin-VARIOUS -1.0
hTERT-AKT -1.0
Mouse, NOS-Embryoid Bodies -1.0
HOPX-PROTEINS -1.0
Actin-Mammalian -1.0
inhibitors-ABLATION -1.0
TAK1-Protein A -1.0
Drive-STANDING -1.0
TREAT-Protein A -1.0
Identified-depend -1.0
Interest-Development -1.0
Cells-striking -1.0
KRAS-Development -1.0
studies-Tet -1.0
transcription factor Nuclear Factor I-Regulated -1.0
TREAT-GATA6 -1.0
Cell Cycle Arrest-Growth arrest -1.0
Chips-Carcinoma, Embryonal -1.0
Activated-TERM -1.0
Differentiation-Chromatin Structure -1.0
Senescence-RAS -1.0
TAK1-inhibitors -1.0
Differentiated-cells differentiation -1.0
STK33-Result -1.0
Elimination-fight -1.0
Transcriptional Networks-Plasmid 0.2
GATA2-Show -1.0
Development-Thought -1.0
inhibitors-Show -1.0
pRB-Tumor Suppressor Proteins -1.0
Identified-Head -1.0
Micro-tubule-Cancer -1.0
study use-Embryonic Stem Cells -1.0
NSCLC-Anaphase Promoting Complex 0.0833
Breast Cancer-Pancreatic Cancer 0.3333
Mutations-Regulation -1.0
KRAS-Cell Growth -1.0
Fibroblasts-RAS -1.0
Progenitor-Plays -1.0
EVENTS-Signaling Molecule -1.0
Interest-LUNG TUMOR -1.0
Relapsing-Cervical Squamous Cell Carcinoma -1.0
Reported-PROTEINS -1.0
Bcl-2-derivatives -1.0
Adenocarcinoma of the Lung-GATA2 Transcription Factor -1.0
Genes-Published -1.0
Cell Cycle Arrest-LEAD -1.0
Ras proteins-State -1.0
Either-GATA2 -1.0
pRB-P19 -1.0
Necrotic-Caspase 8 gene -1.0
Catalytic-Lead 2+ 0.0
studies-Pathway -1.0
pRB-P14 -1.0
Detected-PLK1 -1.0
KRAS-Protein A -1.0
Researchers-EGFR -1.0
mir-223-Selected -1.0
Chromatin-ATP-dependent chromatin remodeling -1.0
Breast Cancer-Clear cell Kidney Cancer -1.0
studies-Inhibiting -1.0
ABT-737-Block -1.0
mir-223-Work -1.0
MDM2-INK4a -1.0
LEAD-RAS -1.0
Adenocarcinoma of the Lung-Enhance -1.0
Cultured Cells-Homologous -1.0
Like-Oncogenes -1.0
Ionising radiation-Genotoxic Stresses -1.0
Clarify-Mice -1.0
Oct-4-Transfection -1.0
Adopted-ATRA -1.0
Mutations-Carrying -1.0
Human-qRT-PCR -1.0
ABLATION-RAS -1.0
Very Important-research data -1.0
studies-Tumor cells -1.0
Block-Oncogens -1.0
Identified-Defined -1.0
-- Leukemia-Pancreatic Cancer 0.0
Caco-2 Cells-HeLa Cells 0.3333
Oct-4-Reports -1.0
bcl-xL-Defined -1.0
in vitro study-mediated -1.0
MDM2-Oncogens -1.0
Production-2-HG -1.0
MCF-MCF7 -1.0
Ras proteins-RAS -1.0
Tumor Suppressor Proteins-MDM2 -1.0
Report-Show -1.0
Carbon-Lethal 0.0909
Alone--- Lung Cancer 0.0
GATA6-Functional Component -1.0
Take-AKT -1.0
Proteasome-Development -1.0
Production-Catalytic -1.0
-- Lung Cancer-Process 0.0
CERVICAL CANCER-overexpress -1.0
Epigenetic-Process -1.0
Regulated-Companions -1.0
TRANSCRIPTION FACTOR-LUNG TUMOR -1.0
Occur-Clarified -1.0
Deletion-Consideration -1.0
Immortalized-AKT -1.0
Chips-cells differentiation -1.0
Human-Reported -1.0
Expression Profiling-Embryoid Bodies -1.0
Senescence-Oncogens -1.0
Mutant-GTP -1.0
Researchers-HOPX -1.0
Phenomena-Phenotype -1.0
Differentiation-Transcript -1.0
KRAS-GATA2 -1.0
Oncogens-NSCLC 0.0833
RAS-STANDING -1.0
KRAS-GATA6 -1.0
Library-Fulfill -1.0
cancer screen-inhibitors -1.0
GATA2-striking -1.0
LEAD-tumor growth -1.0
RIP3-Mediate -1.0
Rest-Malignant -1.0
Progenitor Cell proliferation-Differentiation -1.0
RAS-fight -1.0
Feedback-miRNA 0.0909
GATA6-PROTEINS -1.0
Mutation-striking -1.0
KRAS-Kinase -1.0
P53-Oncogens 0.0833
TET2 Gene-IDH1 -1.0
Bcl-2-bcl-xL -1.0
mir-223-Cells -1.0
Tumors-Very Important -1.0
Response-Stimulated -1.0
Identified-Result -1.0
Cyclin-Dependent Kinase Inhibitor-ACUTE MYELOGENOUS LEUKEMIA -1.0
Breast Cancer-Identified -1.0
TET2-commitment -1.0
TBK1-Tumor cells -1.0
Actin-Nuclear Matrix 0.0667
NSCLC-Responsible -1.0
Pathways-Cells -1.0
Translational Repression-Translational -1.0
IDH2 Gene-Tet -1.0
therapeutics-Tumor cells -1.0
Monitor-Block -1.0
IDH1-ENZYMES -1.0
EC Cell-UTR -1.0
Show-lead increased -1.0
Take-APC -1.0
Agent-Result -1.0
telomerase activity-Cell Survival -1.0
studies-Proteolysis -1.0
Host Defense-inhibitors -1.0
Mediate-Reported -1.0
Mouse, NOS-Oncogens -1.0
LEAD-Transcript -1.0
Oncogens-RAS -1.0
Mcl-1-solid tumors -1.0
Adopted-Regulation -1.0
Reported-Carrying -1.0
Non-Small Cell Lung Cancer-Show -1.0
Transcriptional Networks-Up-Regulation 0.1429
NSCLC-GATA2 -1.0
NSCLC-Wild Type -1.0
NSCLC-GATA6 -1.0
bcl-xL-Cytotoxic -1.0
Reported-DNA hypermethylation -1.0
Clarify-Human Development -1.0
Kinase-localisation -1.0
NSCLC-HOPX -1.0
miRNA-HEPATOCELLULAR CARCINOMA 0.1111
Comparison-GATA2 -1.0
GATA2-Development -1.0
RNA Interference-Pathway -1.0
Murine-DATA SET -1.0
Affect-play -1.0
KRAS-Cells -1.0
Phenomena-TUMORIGENICITY -1.0
20%-KRAS -1.0
Cells-Thought -1.0
Proteolysis-Oncogens 0.1
Mutations-Enzymatic Activity -1.0
WT1-Defined -1.0
BE-Drug Resistance -1.0
Mammalian-Complexes -1.0
Tumor cells-Cell Survival -1.0
Cancer-Models -1.0
STK33-Defined -1.0
AML-IDH1 -1.0
Centrosomes-Work 0.0769
Reports-Translational -1.0
FUNCTIONS OF REPRODUCTION-Response -1.0
G2/M Transition-Cell Cycle -1.0
System-Work -1.0
Process-Scientific -1.0
Cells-look -1.0
Mutant-Advance -1.0
State-MIR-21 -1.0
Differentiated-Differentiation -1.0
therapeutics-Cytotoxic -1.0
Cell types-studies -1.0
GATA2-Drive -1.0
Inhibiting-Regulation -1.0
Selected-Granulocyte -1.0
System-Cells -1.0
STK33-Pathway -1.0
Thought-90% -1.0
Transformation-cervical cancers -1.0
EVENTS-lead increased -1.0
Leukemic Cells-Enzymatic Activity -1.0
Phosphorylation-Plays -1.0
Drive-Anaphase Promoting Complex 0.1
Tissues-Ubiquitin 0.125
these-Pathway -1.0
Thought-RB1 -1.0
Breast Cancer-P53 0.1667
regulation of ribosome biogenesis-Ubiquitin -1.0
20%-LABORATORY -1.0
TET1-ENZYMES -1.0
WAS-Tet -1.0
Granulopoiesis-miRNA -1.0
Differentiation-Maintain -1.0
strategies-Anaphase Promoting Complex -1.0
Oncogens-Drive 0.1
Oct-4-Repression -1.0
AML-ACUTE MYELOGENOUS LEUKEMIA 1.0
KRAS-Mutant -1.0
OVARIAN CANCER-overexpress -1.0
Cancer-Development -1.0
TET2 Gene-Scale -1.0
Reported-Phenotype -1.0
Repression-Tumors 0.1429
Breast Cancer-Reports -1.0
ESC-Cell types -1.0
NSCLC-Cells 0.1111
Oct-4-POU5F1 -1.0
inhibitors-HOPX -1.0
CERVICAL CANCER-localisation -1.0
play-Gene Mutation -1.0
Oct-4-Chromatin Structure -1.0
Show-Proteolytic -1.0
Embryonal Carcinoma Cell-cells differentiation -1.0
Proteasome-bind -1.0
Adopted-NB4S -1.0
apoptotic cell death-Papillary Thyroid Carcinoma -1.0
Activated-Cells -1.0
compromise-Process -1.0
Ubiquitination-Proteolytic -1.0
Human Development-Human 0.0667
Ubiquitination-D1 -1.0
Tumor cells-Mice -1.0
Take-INTERMEDIATE -1.0
Feedback-ANIMAL 0.1111
Mesodermal-tumor growth -1.0
Caveat-Excite -1.0
Like-Cellular Stress Response -1.0
Mutant-Mutation -1.0
cancer screen-Tumor cells -1.0
Phosphorylation-Cultured Cells 0.125
Comparison-Synthetic -1.0
KRAS-Identified -1.0
RAS-Represent -1.0
GATA2-HOPX -1.0
cRaf-KRAS G12D -1.0
inhibitors-Cells -1.0
Mutant-Screen -1.0
Cell Growth-Process -1.0
Show-KRAS -1.0
Monitor-Cell Growth -1.0
Development-TISSUE -1.0
G1 Arrest-Activate -1.0
Thought-Gene Mutation -1.0
Murine-Embryoid Bodies -1.0
Oct-4-Progenitor -1.0
Centrosomes-LATS1 -1.0
-- Leukemia-COLON CANCER 0.0
-- Lung Cancer-Excite 0.0
Phosphorylation-Homologous -1.0
studies-TET1 -1.0
mir-223-miRNA -1.0
Cancer-KRAS -1.0
Granulocyte-Characterized -1.0
Selected-Human Development -1.0
Difference stage-DATA SET -1.0
Cancer-Retinoblastoma -1.0
Ionising radiation-Show -1.0
lung tumors-CRE -1.0
Comprise-Feedback -1.0
Wild Type-Mice -1.0
PPP-Drive 0.1
Agent-GTP -1.0
Progression-Advance -1.0
Show-Telophase -1.0
Tumor cells-Regulated -1.0
Researchers-Show -1.0
TET2-Mutations -1.0
Subunit-Related -1.0
fight-Excite -1.0
KRAS-Related -1.0
Identified-Ionising radiation -1.0
DEATH-Caspase 8 gene -1.0
Primitive-Plays -1.0
Resistance-FAMILY MEMBER -1.0
Examined-play -1.0
Show-Anaphase -1.0
Occur-TUMORIGENICITY -1.0
Reported-Leukemic Cells -1.0
SWI-Complexes -1.0
Tissues-Aurora-A -1.0
Mcl-1-Resistance -1.0
KRAS-RNAi -1.0
Subunit-PROTEINS -1.0
Ras proteins-Cultured Cells 0.1
CERVICAL CANCER-P53 0.1667
Epigenetic Change-Process -1.0
Breast Cancer-overexpress -1.0
Tumor Suppressor-Small Cell Lung Cancers -1.0
STK33-depend -1.0
Viability, Cell-Activities -1.0
Show-Study -1.0
Examined-model -1.0
ES-Up-Regulation 0.1111
miRNA-CHRONIC LYMPHOCYTIC LEUKEMIA 0.1111
Drive-Viability, Cell 0.1111
caspase activity-RIPK1 -1.0
caspase activity-RIPK3 -1.0
P53-Growth arrest -1.0
TET1-Contribute -1.0
Mutant-Wild Type -1.0
Reported-IDH1 Gene Mutation -1.0
Cells-Epigenetic -1.0
Tumor Suppressor Proteins-Genesis -1.0
DNA hypermethylation-IDH2 -1.0
cancer cells-NH2 -1.0
studies-Result -1.0
Human cells-Plasmid -1.0
Take-D1 -1.0
Chemical-Caspase 8 gene -1.0
Examined-aggressive -1.0
Crassa-localisation -1.0
WAS-Mouse, NOS -1.0
Mutant-Either -1.0
Senescence-Gene Expression -1.0
PROTEIN-Model System -1.0
P53-INK4a -1.0
inhibitors-RIPK3 -1.0
inhibitors-RIPK1 -1.0
Cell Growth-Checkpoint -1.0
Relapsing-Tumors -1.0
Erythropoiesis-Human Development 0.1
fight-research data -1.0
Cell Lines-Synthetic -1.0
Human-Cells 0.0714
IDH-cervical cancers -1.0
Study-D1 -1.0
Represent-TISSUE -1.0
Identified-IRS-1 -1.0
Selection-Process -1.0
Work-Line -1.0
Regulation-Line -1.0
Caco-2 Cells-SDS PAGE -1.0
Cells-TISSUE 0.3333
FUNCTIONS OF REPRODUCTION-Sequence -1.0
GATA2-Oncogens -1.0
Production-Enzymatic Activity -1.0
Account #-GATA2 0.0
IDH2 Gene-Inhibiting -1.0
cancer cells-Cyclin-D1 -1.0
Tumors-Tumor specimens -1.0
Transcriptional Network-Cells 0.1111
Actin-BAF53 -1.0
GATA2-TREAT -1.0
Tumors-Phenomena -1.0
Caco-2 Cells-Western Blotting 0.1111
HOPX-Checkpoint -1.0
MIR-21-Target site -1.0
Signaling Pathways-Regulated -1.0
TET2-DNA hypermethylation -1.0
Phosphorylation Site-THREONINE -1.0
CERVICAL CANCER-LYMPHOMA 0.3333
LEAD-TRAF6 0.0909
Regulation-PLK1 -1.0
Comparison-Models -1.0
Oncogens-c-Raf -1.0
Papillary Carcinoma of the Thyroid-Absence -1.0
studies-IDH1 -1.0
ANALYSIS-Carcinoma, Embryonal 0.1429
Primitive-POU5F1 -1.0
Mice-GATA6 -1.0
Process-Understand -1.0
KRAS-Viability, Cell -1.0
System-NB4S -1.0
Repression-Gene Mutation -1.0
20%-GATA2 -1.0
P53-Cancer -1.0
studies-Mutations -1.0
PC9-localisation 0.0
RAS-Cellular Stress Response -1.0
Ionising radiation-Activate -1.0
HeLa-VARIOUS -1.0
Activated-State -1.0
NSCLC-Show -1.0
Nuclear Matrix-PROTEINS 0.0833
RAS-research results -1.0
Phosphorylation-G2/M Transition -1.0
Immortalized-Cell Growth -1.0
Centrosomes-Cancer -1.0
Differentiated-Chips -1.0
Transcriptional Network-Anaphase Promoting Complex 0.0833
ESC-Published -1.0
KRAS-Agent -1.0
IDH2 Mutation-Tet -1.0
Cells-Aurora-A -1.0
Catalytic-IDH1 Mutation -1.0
Human-Point A -1.0
Oncogene-Human cells -1.0
Tissues-ligase inhibitor -1.0
inhibitors-Caspase Inhibitors -1.0
Reported-Enzymatic Activity -1.0
Selected-Show -1.0
Identified-Researchers -1.0
Cancer-Reported -1.0
Drive-fight -1.0
Repression-TUMOR 0.1429
research results-Process -1.0
Alone-STANDING -1.0
Promote-tumor growth -1.0
CERVICAL CANCER-HEPATOCELLULAR CARCINOMA 0.3333
Cyclin-Dependent Kinases-Growth arrest -1.0
Binding-Absence -1.0
TREAT-HOPX -1.0
Cyclin-Dependent Kinases-LEAD 0.1111
Mouse, NOS-LUNG TUMOR -1.0
WAS-ENZYMES 0.125
studies-Protein A -1.0
Agent-Protein A -1.0
RIP1-Motif -1.0
Anaphase-Consideration -1.0
MIR-21-Screen -1.0
Mouse, NOS-Repression -1.0
Show-Skin -1.0
Progenitor Cell proliferation-used -1.0
Plays-Homologous -1.0
Mutant-Represent -1.0
ACUTE MYELOGENOUS LEUKEMIA-IDH2 Gene -1.0
Centrosomes-Cell Lines 0.1
RNAi-Fulfill -1.0
Erythropoiesis-Myelopoiesis 0.25
Binding-Complexes -1.0
Advance-Excite -1.0
Thought-Phenotype -1.0
miRNA-INSULIN RECEPTOR SUBSTRATE 1 -1.0
EC Cell-Point A -1.0
IDH-Block -1.0
Cyclin-D1-THREONINE -1.0
Trigger-Reported -1.0
used-algorithm -1.0
ACUTE MYELOGENOUS LEUKEMIA-IDH1 Mutation -1.0
WAS-Retinoblastoma 0.1667
DEATH-Process -1.0
CCAAT Enhancer Binding Protein-Regulated -1.0
Human-Cancer -1.0
RAS Oncogene-degradation of cyclin -1.0
Roles-Mice 0.0625
TRAF6-virus 0.1
Mice-Mouse, NOS -1.0
KRAS-Wild Type -1.0
Mcl-1-therapeutics -1.0
CERVICAL CANCER-Regulated -1.0
Leukemic Cells-Phenotype -1.0
Phosphorylation-Skin 0.125
bcl-xL-FAMILY MEMBER -1.0
telomerase activity-lead increased -1.0
Ectodermal-Stem Cells -1.0
mek-Protein A -1.0
BAF53-ATP-dependent chromatin remodeling -1.0
Cancer-serine/threonine-protein kinase -1.0
Subunit-Complexes -1.0
-- Leukemia-Head 0.0
Signaling Pathways-inhibitors -1.0
PC9-Functional Component 0.0
Tissues-PLK1 -1.0
NIH 3T3 Cells-Oncogenes 0.0667
pRB-play -1.0
HeLa-MCF7 -1.0
Thought-cumulative gene -1.0
Breast Cancer-Oncogene 0.0833
EC Cell-Renilla -1.0
Differentiated-Murine -1.0
Identified-Permit -1.0
Differentiated-Difference stage -1.0
PC9-PROTEINS 0.0
Progenitor-Stem Cells -1.0
Mouse, NOS-Promoter -1.0
CERVICAL CANCER-Detected -1.0
Signaling Pathways-Drive -1.0
ANALYSIS-DATA SET 0.125
Senescence-Fibroblasts -1.0
Senescence-NIH 3T3 Cells -1.0
Breast Cancer-CYCLIN E 0.1
lung tumors-Lung Infection -1.0
Oct-4-Embryonal Carcinoma Cell -1.0
Drive-Advance -1.0
Tissues-Regulated -1.0
GATA2-Process -1.0
Comprise-transcription factor Nuclear Factor I -1.0
localisation-Maturation -1.0
Senescence-Cells -1.0
Identified-Breast Cancer Cell -1.0
GATA2-inhibitors -1.0
Difference stage-Cell types -1.0
NF1-transcription factor Nuclear Factor I -1.0
kill-Result -1.0
caspase activity-Caspase 8 gene -1.0
RAS Oncogene-Ionising radiation -1.0
Actin-ATP-dependent chromatin remodeling -1.0
Tumorigenesis-Understand -1.0
Genotoxic Stress-Genotoxic Stresses 1.0
Senescence-Oncogenes -1.0
Wild Type-Pathways -1.0
Cell Cycle Arrest-RAS -1.0
EGFR-Tumorigenesis -1.0
Embryonal Carcinoma Cell-VARIOUS -1.0
Regulated-Complexes -1.0
TRAF6-LOX -1.0
P53-P14 -1.0
Oct-4-qRT-PCR -1.0
Interest-Oncogens -1.0
Differentiation-Plays -1.0
ES-Renilla 0.0909
P53-P19 -1.0
Cancer-P14 -1.0
Mouse, NOS-Transfection -1.0
CERVICAL CANCER--- Leukemia 0.0
strategies-Degraded -1.0
Mcl-1-Regression -1.0
Alone-Very Important -1.0
TRANSCRIPTION FACTOR-Oncogens 0.125
Expression Profiling-Embryonic Stem Cells -1.0
Wild Type-Regulated -1.0
Production-Carrying -1.0
Cancer-P19 -1.0
Occur-Thought -1.0
Represent-Phenomena -1.0
Proteasome-GATA2 Transcription Factor 0.1
Aurora-A kinase-Roles 0.0833
TET2-Survey -1.0
GATA2-depend -1.0
ES-Reports -1.0
Mutant-Pathway -1.0
mek-Mutation -1.0
CERVICAL CANCER-CHRONIC LYMPHOCYTIC LEUKEMIA 0.3333
TRANSCRIPTION FACTOR-RAS -1.0
cancer cells-Stress -1.0
Inhibition-Protein A 0.1
CERVICAL CANCER-Human 0.0667
Mcl-1-derivatives -1.0
Non-Small Cell Lung Cancer-KRAS G12D -1.0
-- Leukemia-Oncogene 0.0
Mutant-TREAT -1.0
Deletion-Homolog -1.0
Lethal-striking -1.0
Phosphorylation-Aurora-A -1.0
ABT-737-solid tumors -1.0
TET2-TET2 Gene -1.0
Aurora-A kinase-PLK1 -1.0
Regulated-Viability, Cell -1.0
Occur-Process -1.0
miRNAs-Show -1.0
Adenocarcinoma of the Lung-bind -1.0
Normal cell division-TUMORIGENICITY -1.0
Oct-4-tumor growth -1.0
Relapsing-Head -1.0
Nucleotides-RNA 0.25
Tumors-Development -1.0
LATS2-Cell Cycle -1.0
CERVICAL CANCER-INSULIN RECEPTOR SUBSTRATE 1 -1.0
Proteolysis-LEAD 0.1
Cells-Protein A 0.125
DNA hypermethylation-IDH1 Mutation -1.0
Pancreatic Cancer-CYCLIN E 0.1
Proteasome-RAS -1.0
Cultured Cells-LATS1 -1.0
Oct-4-Chips -1.0
Reported-Study -1.0
Cells-LATS 0.0909
play-Tumors -1.0
DNA hypermethylation-Lead 2+ 0.0
-- Prostate Cancer-Stimulated 0.0
TREAT-Cells -1.0
AML-Genomic -1.0
Crassa-Affect -1.0
necroptosis-inhibitors -1.0
Cancer-Show -1.0
EVENTS-Hallmark Cell -1.0
IL1-Cells -1.0
IDH-Carrying -1.0
G1 Arrest-Show -1.0
GATA2-Promoter -1.0
Bcl-2-Block -1.0
Genotoxic Stresses-Reported -1.0
virus infection-compromise -1.0
Occur-Study -1.0
Oct-4-cells differentiation -1.0
TBK1-Protein A -1.0
Genes-Companions -1.0
Retinoblastoma Protein-Retinoblastoma 1.0
Tumor Suppressor Proteins-Retinoblastoma 0.5
Chips-VARIOUS -1.0
Malignant-Represent -1.0
Aurora-A-MIR-145 -1.0
GATA2-EGFR -1.0
CERVICAL CANCER-Reports -1.0
NF1-Granulopoiesis -1.0
Relapsing-LYMPHOMA -1.0
Anaphase-N NOS -1.0
Tumor Suppressor-Neural Tumors -1.0
Tumors-Tet -1.0
Signaling Pathways-NSCLC -1.0
ACUTE MYELOGENOUS LEUKEMIA-Reported -1.0
Relapsing--- Lung Cancer 0.0
Identified-Cervical Squamous Cell Carcinoma -1.0
play-TUMOR -1.0
strategies-Cyclin-D1 -1.0
Embryonal Carcinoma Cell-Carcinoma, Embryonal 0.1111
Mutant-look -1.0
miRNA-Cervical Squamous Cell Carcinoma -1.0
IDH2 Gene-Scale -1.0
Haematopoiesis-Mice 0.0625
Myeloid Differentiation-mediated -1.0
Tumors-Advance -1.0
RIP1-Reported -1.0
PC9-centrosomin 0.0
Relapsing-Human -1.0
mir-223-Human -1.0
Wild Type-GATA2 -1.0
metastasis-IRS-1 -1.0
NSCLC-EGFR -1.0
WAS-TUMOR 0.2
Relapsing-Breast Cancer Cell -1.0
Adenocarcinoma of the Lung-LUNG TUMOR -1.0
MCF-HeLa Cells -1.0
Drive-D1 -1.0
Crassa-Consideration -1.0
Differentiation-DATA SET -1.0
TET2 Gene-IDH2 Mutation -1.0
TREAT-inhibitors -1.0
Centrosomes-Cell Proliferation 0.0667
Human Development-Characterized -1.0
EC Cell-Cells -1.0
Lesion-Reported -1.0
Reported-Catalytic -1.0
Wild Type-Fulfill -1.0
Senescence-State -1.0
Epigenetic-Phenomena -1.0
pRB-TUMOR -1.0
Cancer-AS gene -1.0
Mutant-fight -1.0
Bcl-2-therapeutics -1.0
combinations-Cells -1.0
strategies-depend -1.0
Immortalized-Hallmark Cell -1.0
Like-Result -1.0
LATS2-MIR-145 -1.0
Roles-Myelopoiesis 0.0769
Proteasome-LUNG TUMOR -1.0
TET2-Occur -1.0
TRAF6-Tumors regression -1.0
miRNA-Carcinoma, Thyroid 0.1111
Identified-Protein A -1.0
NSCLC-D1 -1.0
RAS--- Lung Cancer 0.0
Nuclear Matrix-Complexes -1.0
LATS2-Cultured Cells -1.0
Show-INTERMEDIATE -1.0
Proliferative-Absence -1.0
Mutation-GTP 0.0909
Reported-NDEL1 -1.0
TRAF6-CRE -1.0
miRNA-Human 0.0588
Branch-Lethal -1.0
CERVICAL CANCER-PLK1 -1.0
Transcriptional Networks-UTR -1.0
IDH2 Gene-IDH2 Mutation -1.0
OVARIAN CANCER-Absence -1.0
LEAD-Development -1.0
Ras proteins-Cells 0.1111
pRB-Proteolysis -1.0
Regulated-Reported -1.0
pRB-MDM2 -1.0
strategies-NH2 -1.0
anti-apoptosis-Model System -1.0
RAS-Advance -1.0
BAF53-PROTEINS -1.0
Lesion-Tumor specimens -1.0
Oct-4-SEQUENCING -1.0
Transcription Factors-transcription factor Nuclear Factor I -1.0
Trigger-studies -1.0
Cell Lines-Lethal 0.0909
Related-inhibitors -1.0
Mutant-NSCLC -1.0
IL1-D1 -1.0
Phenomena-EVENTS -1.0
Response-P53 -1.0
Phosphorylation Site-degradation of cyclin -1.0
Study-Ionising radiation -1.0
Necrotic-RIPK3 -1.0
P53-Rodent 0.0714
Necrotic-RIPK1 -1.0
cRaf-Show -1.0
EGFR-NDEL1 -1.0
PC9-Checkpoint 0.0
Development-Process -1.0
solid tumors-Cytotoxic -1.0
Mesodermal-Plays -1.0
Mutant-Drive -1.0
Epigenetic Change-Normal cell division -1.0
Fibroblasts-Alone -1.0
KRAS-depend -1.0
Cyclin-Dependent Kinases-Rodent 0.0769
Oct-4-UTR -1.0
Mouse, NOS-SEQUENCING -1.0
IDH2 Mutation-Mutations -1.0
Haematopoiesis-Granulocyte 0.1
RNA Interference-Tumor cells -1.0
Breast Cancer-Stimulated -1.0
Related-Regulated -1.0
Mouse, NOS-Cell types -1.0
AN-ligase inhibitor -1.0
miRNA-Translational -1.0
Phosphorylation-Show -1.0
TAK1-Permit -1.0
RAS Oncogene-D1 -1.0
PPP-KRAS -1.0
LATS2-Regulated -1.0
ABT-737-Tumor cells -1.0
ESC-Embryoid Bodies -1.0
Plays-Roles -1.0
Telophase-play -1.0
inhibitors-Death Receptors -1.0
WAS-Inhibiting -1.0
Human cells-Point A -1.0
HOPX-Aurora-A -1.0
Malignant--- Lung Cancer 0.0
look-Result -1.0
Human-Genesis -1.0
neoplastic transformation-TUMORIGENICITY -1.0
Human Development-specific -1.0
telomerase activity-serine/threonine-protein kinase -1.0
Tumor regression-Represent -1.0
TREAT-Mutation -1.0
Study-Responsible -1.0
Wild Type-Researchers -1.0
Screen-Fulfill -1.0
Activated-Cell Cycle -1.0
TET2-Scale -1.0
Examined-Consideration -1.0
Pancreatic Cancer-Absence -1.0
Oct-4-Mesodermal -1.0
Difference stage-Embryonic Stem Cells -1.0
Electroporation-Construct -1.0
Difference stage-Embryoid Bodies -1.0
Inhibition-Defined -1.0
used-Target site -1.0
Deletion-N NOS -1.0
in vitro study-RNAi -1.0
GATA6-centrosomin -1.0
WT1-Result -1.0
Nuclear Matrix-ATP-dependent chromatin remodeling -1.0
Adopted-Promoter -1.0
Mutation-Protein A 0.1
Endodermal-Chromatin Structure -1.0
CERVICAL CANCER--- Lung Cancer 0.0
Mouse, NOS-qRT-PCR -1.0
Report-MIR-21 -1.0
EC Cell-Plasmid -1.0
Tumor Suppressor Proteins-Ubiquitin 0.2
Identified-Cells -1.0
Growth arrest-Like -1.0
MDM2-LEAD -1.0
PPP-LABORATORY 0.1
apoptotic cell death-Regulated -1.0
Cells-TERM -1.0
Stem-mediated -1.0
TET2-Stem -1.0
Expression Profiling-Carcinoma, Embryonal -1.0
Response-CYCLIN E -1.0
mir-223-Granulopoiesis -1.0
caspase activity-kinase activity -1.0
RIP1-Mediate -1.0
Cell Cycle Progression-Homolog -1.0
DNA hypermethylation-Carrying -1.0
Retinoblastoma Protein-TUMOR 0.125
Represent-neoplastic transformation -1.0
BY-Proteolysis -1.0
Cyclin-D1-Proteolytic -1.0
Progenitor Cell proliferation-Lanugo -1.0
G1 Arrest-Genotoxic Stress -1.0
CCAAT Enhancer Binding Protein-System -1.0
Lanugo-Work -1.0
IDH-IDH1 Gene Mutation -1.0
Reported-Aurora-A -1.0
Flow-Models -1.0
pRB-Repression -1.0
WAS-Contribute -1.0
apoptotic cell death-Tumor cells -1.0
Regulation-Cells -1.0
hTERT-Cell metabolism -1.0
Clarify-Granulocyte -1.0
CERVICAL CANCER-CYCLIN E 0.1
Leukemic Cells-2-HG -1.0
TBK1-inhibitors -1.0
Embryonal Carcinoma Cell-DATA SET 0.0909
Tumor cells-Pathways -1.0
metastasis-Human 0.0625
Entry-Work -1.0
Host Defense-Chemical -1.0
Activated-Fibroblasts -1.0
Malignant-research results -1.0
CERVICAL CANCER-Head 0.2
Pancreatic Cancer-overexpress -1.0
LATS2-Cell Proliferation -1.0
Human cells-Reagent -1.0
Tumor cells-serine/threonine-protein kinase -1.0
DNA hypermethylation-Metabolite -1.0
miRNA-Show -1.0
inhibitors-PC9 0.0
Cells-kill -1.0
AN-Tissues 0.2
Cyclin-D1-Genotoxic Stress -1.0
Either-Show -1.0
Chemical-Caspase Inhibitors -1.0
mir-223-NB4S -1.0
Production-IDH2 -1.0
CERVICAL CANCER-Tissues 0.1667
Regulation-Promoter -1.0
IDH-Phenotype -1.0
Cancer-MDM2 -1.0
Phosphorylation-D1 -1.0
mek-Permit -1.0
Aurora-A-Block -1.0
IDH1 Mutation-Clarified -1.0
Production-Isocitrate Dehydrogenase -1.0
Mouse, NOS-Carcinoma, Embryonal -1.0
GATA2-Mice -1.0
Granulopoiesis-Regulated -1.0
Catalytic-Block -1.0
Carbon-LABORATORY 0.1111
Take-degradation of cyclin -1.0
Genotoxic Stresses-studies -1.0
Advance-research data -1.0
ES-SEQUENCING -1.0
ESC-Carcinoma, Embryonal -1.0
HOPX-Process -1.0
Papillary Carcinoma of the Thyroid-P53 -1.0
APC-Genotoxic Stresses -1.0
20%-Models -1.0
Erythropoiesis-Show -1.0
Screen-GATA2 -1.0
Centrosomes-Promote -1.0
Identified-inhibitors -1.0
DNA hypermethylation-Tumors -1.0
studies-Mutation -1.0
Leukemic Cells-Tumors -1.0
LATS2-Mitosis -1.0
GATA6-LATS -1.0
Show-Granulocyte -1.0
Clarify-Show -1.0
Study-Feedback -1.0
IDH1-Contribute -1.0
ENZYMES-cervical cancers -1.0
Detected-Roles -1.0
Development-cumulative gene -1.0
Mcl-1-Work -1.0
TET2 Gene-Redundant -1.0
Caco-2 Cells-Analyzed -1.0
WAS-Oct-4 -1.0
Progression-Represent -1.0
Crassa-Examined -1.0
Phosphorylation-Mitosis 0.1111
TET2 Gene-Genomic -1.0
Examined-Homolog -1.0
Study-transcription factor Nuclear Factor I -1.0
DEATH-Show -1.0
P53-RAS -1.0
Chemical-Death Receptors -1.0
IDH1 Mutation-IDH2 Mutation -1.0
pRB-LEAD -1.0
Human cells-qRT-PCR -1.0
Human gene-Fulfill -1.0
Erythropoiesis-Granulocyte 0.0909
RAS-Very Important -1.0
Cells-Kinase 0.125
Tumor regression-TRAF6 -1.0
RAS Oncogene-Cells -1.0
Production-Tumors -1.0
Tissues-localisation -1.0
Identified-Human -1.0
WAS-ES 0.1667
Take-Proteolytic -1.0
HOPX-LATS -1.0
Mouse, NOS-Up-Regulation -1.0
Rest-Suppressor -1.0
Anaphase-play -1.0
Retinoblastoma Protein-90% -1.0
Cell Cycle Progression-play -1.0
Inhibition-depend -1.0
Proteolysis-INK4a -1.0
Breast Cancer-INSULIN RECEPTOR SUBSTRATE 1 -1.0
Oct-4-studies -1.0
Ionising radiation-studies -1.0
ABLATION-Oncogens -1.0
Show-Deletion -1.0
Reported-Clarified -1.0
ABLATION-Development -1.0
EVENTS-Cell Survival -1.0
pRB-Oncogens -1.0
Comparison-AS gene -1.0
Differentiated-study use -1.0
Cancer-Tumor cells -1.0
NSCLC-Carrying -1.0
Relapsing-COLON CANCER -1.0
kill-striking -1.0
transcription factor Nuclear Factor I-Transcription -1.0
Mutant-Protein A -1.0
Relapsing-Reports -1.0
Bcl-2-Cancer -1.0
MICROARRAY-Embryoid Bodies -1.0
Cells-Oncogenes 0.0909
WT1-Mutation 0.125
Ras proteins-Tumor Suppressor -1.0
Actin-Subunit -1.0
Very Important-Excite -1.0
cancer screen-Permit -1.0
Wild Type-Drive -1.0
Aurora-A kinase-MIR-145 -1.0
Endodermal-Pluripotent Stem Cell -1.0
studies-Defined -1.0
-- Leukemia-Human 0.0
Stem-Differentiation -1.0
TET2 Gene-Show -1.0
AML-Survey -1.0
AML-Show -1.0
Growth arrest-Cellular Stress Response -1.0
TET2 Gene-Mutations -1.0
Promote-Chromatin Structure -1.0
Differentiated-Cell types -1.0
Reported-localisation -1.0
Take-Cell Growth -1.0
Carrying-GATA2 -1.0
apoptotic cell death-Block -1.0
Difference stage-cells differentiation -1.0
Cancer-Cell Survival -1.0
solid tumors-Tumor cells -1.0
DEATH-RIPK3 -1.0
Phosphorylation-Activated -1.0
Tumors-Contribute -1.0
DEATH-RIPK1 -1.0
Work-Study -1.0
Differentiated-DATA SET -1.0
these-Lesion -1.0
LEAD-Very Important -1.0
LEAD--- Lung Cancer 0.0
Monitor-MIR-21 -1.0
bcl-xL-Protein A -1.0
Epigenetic Change-Thought -1.0
Breast Cancer-IRS-1 -1.0
strategies-Binding -1.0
G2/M Transition-Homologous -1.0
EGFR-Activities -1.0
TET2-Enzymatic Activity -1.0
Progression-Consideration -1.0
Mutations-Phenotype 0.25
hTERT-lead increased -1.0
Represent-Thought -1.0
Rest-Transformation -1.0
Thought-Exhibit -1.0
KRAS-Regulated -1.0
Interest-Promoter -1.0
TRANSCRIPTION FACTOR-Promoter -1.0
metastasis-Oncogene 0.0769
Development-overexpress -1.0
Cancer-c-Raf -1.0
Viability, Cell-Aurora-A -1.0
Retinoblastoma Protein-RB1 1.0
LATS2-MIR-21 -1.0
HOPX-Activities -1.0
Regulation-CDK5RAP2 -1.0
EGFR-centrosomin -1.0
Elimination-Very Important -1.0
pRB-RAS -1.0
metastasis-Show -1.0
pRB-RB1 -1.0
P53-Senescence -1.0
inhibitors-Reported -1.0
Oct-4-Embryonic Stem Cells -1.0
Alone-fight -1.0
LEAD-Plays -1.0
Cancer-AKT -1.0
research results-Drug Discovery -1.0
P53-Reported -1.0
Senescence-Result -1.0
pRB-90% -1.0
Proteasome-Cells 0.125
Block-Rodent -1.0
Work-ATRA -1.0
Epigenetic Change-Epigenetic -1.0
Myeloid Differentiation-used -1.0
Mcl-1-Block -1.0
CERVICAL CANCER-Cervical Squamous Cell Carcinoma -1.0
Host Defense-compromise -1.0
Identified-D1 -1.0
Bcl-2-Tumor cells -1.0
Activated-LATS1 -1.0
mek-Defined -1.0
Binding-CYCLIN E -1.0
Epigenetic Change-TISSUE -1.0
mir-223-Clarify -1.0
GATA6-Process -1.0
look-Kinase -1.0
AML-Scale -1.0
Normal cell division-Phenotype -1.0
Tumorigenesis-Tumor Progression -1.0
Adopted-Work -1.0
CCAAT Enhancer Binding Protein-NF1 0.0909
mir-223-Characterized -1.0
ANALYSIS-cells differentiation -1.0
GATA2-Tumor cells -1.0
Promote-Plays -1.0
Breast Cancer-LYMPHOMA 0.3333
TREAT-Reported -1.0
Detected-localisation -1.0
Carbon-GATA2 -1.0
LEAD-POU5F1 -1.0
CERVICAL CANCER-Tumors 0.5
Deletion-localisation -1.0
human cell lines-GATA2 -1.0
Cancer-Exhibit -1.0
Crassa-play -1.0
Occur-Cells -1.0
EGFR-Checkpoint -1.0
compromise-Show -1.0
Immortalized-serine/threonine-protein kinase -1.0
Cell Cycle Arrest-Senescence -1.0
Pathways-EGFR -1.0
Pathways-Cell Growth -1.0
Wild Type-TREAT -1.0
signalling-degradation of cyclin -1.0
human cell lines-Fulfill -1.0
TET2-Promoter -1.0
Regulated-VARIOUS -1.0
Oct-4-Mouse, NOS -1.0
neoplastic transformation-Phenotype -1.0
Mcl-1-roscovitine -1.0
WAS-EC Cell -1.0
Retinoblastoma Protein-Exhibit -1.0
Oct-4-Reagent -1.0
Drug Resistance-FASUDIL -1.0
CERVICAL CANCER-LATS2 -1.0
lung tumors-Sporadic -1.0
Occur-Normal cell division -1.0
Catalytic-2-HG -1.0
TET1-Mutations -1.0
Cancer-LABORATORY -1.0
research results-Excite -1.0
Reported-Isocitrate Dehydrogenase -1.0
Mice-Cell Growth -1.0
Mutant-human cell lines -1.0
strategies-Tumor cells -1.0
cancer cells-Sequence -1.0
Differentiated-Embryonic Stem Cells -1.0
Flow-KRAS -1.0
Wild Type-Show -1.0
P53-APC 0.3333
cancer screen-Result -1.0
transcription factor Nuclear Factor I-ANIMAL -1.0
study use-cells differentiation -1.0
PROTEIN-ABT-737 -1.0
DEATH-kinase activity -1.0
Mutations-RAS -1.0
Identified-INSULIN RECEPTOR SUBSTRATE 1 -1.0
Reported-Lead 2+ 0.0
Occur-Show -1.0
Cyclin-D1-Activate -1.0
IDH2 Gene-Study -1.0
Cyclin-Dependent Kinases-Oncogens 0.1111
Bcl-2-Resistance -1.0
Differentiation-Embryoid Bodies -1.0
IDH2 Mutation-Transformation -1.0
IDH1-Tet -1.0
mir-223-Transcription -1.0
Selection-Phenomena -1.0
KRAS-Permit -1.0
GATA2-Identified -1.0
mir-223-Feedback -1.0
GATA2-NDEL1 -1.0
Oct-4-Point A -1.0
Endodermal-Stem Cells -1.0
P53-Proteolysis 0.1111
Library-Show -1.0
TET2-Study -1.0
Catalytic-Metabolite -1.0
transcription factor Nuclear Factor I-miRNAs -1.0
KRAS-kill -1.0
metastasis-CHRONIC LYMPHOCYTIC LEUKEMIA 0.25
Cancer-Block -1.0
Progenitor Cell proliferation-studies -1.0
ES-Repression 0.125
Regulation-Aurora-A -1.0
Regression-Tumor cells -1.0
Occur-TISSUE -1.0
Oct-4-LEAD -1.0
Stem-RNAi -1.0
strategies-Stress -1.0
Regulation-Cell Differentiation -1.0
Ectodermal-tumor growth -1.0
in vitro study-studies -1.0
WAS-IDH -1.0
Tumor regression--- Lung Cancer 0.0
WAS-Mutations 0.1111
Mouse, NOS-RAS -1.0
Feedback-Regulated -1.0
Human-LATS2 -1.0
Viability, Cell-PROTEINS 0.125
Mcl-1-Cancer -1.0
Represent-Phenotype -1.0
Proteasome-Ionising radiation -1.0
Malignant-Very Important -1.0
Reported-CERVICAL CANCER -1.0
Identified-TREAT -1.0
telomerase activity-Signaling Molecule -1.0
Genes-Mice 0.0588
Activated-Gene Expression -1.0
Cancer-FAMILY MEMBER -1.0
UP-LATS2 -1.0
compromise-Caspase Inhibitors -1.0
Occur-Scale -1.0
Progenitor-Pluripotent Stem Cell -1.0
State-Show -1.0
Breast Cancer-Absence -1.0
in vitro study-commitment -1.0
Differentiated-ESC -1.0
compromise-kinase activity -1.0
Mice-specific -1.0
Carbon-KRAS -1.0
Cells-centrosomin -1.0
ES-Point A -1.0
Feedback-miRNAs 0.0909
necroptosis-Chemical -1.0
Branch-Drive -1.0
TET1-Inhibiting -1.0
KRAS-Screen -1.0
Viability, Cell-NDEL1 -1.0
UP-apoptotic cell death -1.0
Progenitor-tumor growth -1.0
metastasis-Breast Cancer Cell -1.0
Regulated-Published -1.0
GATA2-Aurora-A -1.0
HOPX-localisation -1.0
Immortalized-INTERMEDIATE -1.0
Ras proteins-Alone -1.0
Process-studies -1.0
Cancer-Ubiquitin -1.0
GATA2-degradation of cyclin -1.0
regulation of ribosome biogenesis-P19 -1.0
Cancer-Hallmark Cell -1.0
Cells-neoplastic transformation -1.0
ABLATION-bind -1.0
Cancer-lead increased -1.0
Actin-Binding -1.0
RAS-Oncogenes -1.0
Target Gene-MIR-21 -1.0
Cancer-90% -1.0
Centrosomes-cervical cells -1.0
Viability, Cell-Process -1.0
Cancer-RAS -1.0
IDH2 Gene-Mutations -1.0
Cancer-RB1 -1.0
regulation of ribosome biogenesis-P14 -1.0
Ionising radiation-Reported -1.0
Proteasome-D1 -1.0
Advance-Process -1.0
KRAS-PC9 0.0
Rest-BREAST 0.1111
Leukemic Cells-Isocitrate Dehydrogenase -1.0
GATA6-Show -1.0
Mutant-Carrying -1.0
IDH2 Gene-ENZYMES -1.0
Mcl-1-apoptotic cell death -1.0
localisation-Aurora-A -1.0
fight-Drug Discovery -1.0
HOPX-Tumorigenesis -1.0
RNA Interference-Mutation 0.125
Epigenetic-TUMORIGENICITY -1.0
TET2-Genomic -1.0
Progression-localisation -1.0
Kinase-N NOS -1.0
LEAD-Pluripotent Stem Cell 0.1
mir-223-specific -1.0
Identified-COLON CANCER -1.0
cRaf-KRAS -1.0
mir-223-Erythropoiesis -1.0
Progenitor Cell proliferation-RNAi -1.0
AML-Study -1.0
Represent-research data -1.0
KRAS-GTP -1.0
apoptotic cell death-CERVICAL CANCER -1.0
miRNA-COLON CANCER 0.1111
Trigger-Proteolysis -1.0
Human-Up-Regulation 0.0588
Production-IDH1 Mutation -1.0
Endodermal-Plays -1.0
therapeutics-FAMILY MEMBER -1.0
Drive-degradation of cyclin -1.0
Show-Signaling Molecule -1.0
Inhibition-inhibitors -1.0
Regulated-Cell Growth -1.0
combinations-D1 -1.0
STANDING-Process -1.0
Selected-Mice -1.0
Show-Box -1.0
Drug Resistance-Wild Type -1.0
Reported-Scale -1.0
Cell Lines-GATA2 -1.0
LATS2-Roles -1.0
pRB-Rodent -1.0
Show-Progression -1.0
Represent-EVENTS -1.0
Cancer-GATA2 -1.0
-- Leukemia-Breast Cancer Cell 0.0
mir-223-Mice -1.0
NSCLC-Drive 0.0909
Human-Pathway -1.0
TBK1-Pathway -1.0
GATA6-NDEL1 -1.0
transcription factor Nuclear Factor I-System -1.0
Tumor regression-bind -1.0
Drug Resistance-aggressive -1.0
Cyclin-D1-Box -1.0
Tumor Suppressor-Transformation -1.0
Comparison-Drive -1.0
Nuclear Matrix-Related -1.0
Granulocyte-Mouse, NOS -1.0
Epigenetic-Phenotype -1.0
TET2-LED -1.0
HeLa-Construct -1.0
used-Fold -1.0
GATA2-kill -1.0
mir-223-Haematopoiesis -1.0
CAAT-Enhancer Binding Protein-Granulopoiesis -1.0
strategies-CELL -1.0
Human cells-Microarray Analysis -1.0
Cells-localisation -1.0
Oncogens-Development -1.0
IDH2 Gene-Survey -1.0
NSCLC-Screen -1.0
Branch-Models -1.0
kill-GTP -1.0
Anaphase-localisation -1.0
Ionising radiation-Genotoxic Stress -1.0
SWI-Related -1.0
LATS2-Detected -1.0
Ras proteins-RAS Oncogene -1.0
Genes-inhibitors -1.0
Show-Genotoxic Stresses -1.0
Work-All-trans Retinoic Acid -1.0
pRB-Tumors -1.0
Plays-Aurora-A -1.0
Cells-Agent -1.0
mek-depend -1.0
Production-IDH1 Gene Mutation -1.0
miRNA-Pancreatic Cancer 0.1111
Reported-Tumorigenesis -1.0
NSCLC-Human gene -1.0
Tumor Suppressor-Deregulation -1.0
Signaling Pathways-Researchers -1.0
PC9-LATS 0.0
Show-Consideration -1.0
Tumor Suppressor Proteins-Tumors 0.125
Caveat-research data -1.0
IDH1 Mutation-Survey -1.0
Human-UTR -1.0
Myelopoiesis-Mouse, NOS -1.0
MDM2-RAS -1.0
Human-Retinoblastoma 0.0667
RIP1-Show -1.0
Resistance-Block -1.0
Like-TERM -1.0
roscovitine-ACUTE MYELOGENOUS LEUKEMIA -1.0
Tumor Suppressor Proteins-90% -1.0
Breast Cancer-metastasis 0.25
WAS-Transcriptional Networks 0.0909
Human cells-Study -1.0
Tumor Suppressor Proteins-RB1 0.5
MCF-Protein Expression -1.0
model-LUNG TUMOR -1.0
CERVICAL CANCER-Relapsing -1.0
AN-pRB -1.0
metastasis-COLON CANCER 0.25
Work-Promoter -1.0
Cell Growth-centrosomin -1.0
CCAAT Enhancer Binding Protein-Transcription -1.0
LEAD-Represent -1.0
UP-G2/M Arrest -1.0
Mutant-Lethal -1.0
Mouse, NOS-CO -1.0
strategies-Pathway -1.0
Actin-Chromatin 0.1667
metastasis-Cervical Squamous Cell Carcinoma -1.0
CERVICAL CANCER-Absence -1.0
Granulocyte-Human 0.0625
Lanugo-ABT-737 -1.0
Differentiation-cells differentiation -1.0
Oct-4-Cell types -1.0
Granulopoiesis-Transcription -1.0
TET2-in vitro study -1.0
Phosphorylation-Cell Growth -1.0
Catalytic-Phenotype -1.0
strategies-Protein A -1.0
ABLATION-Promoter -1.0
Differentiated-Embryoid Bodies -1.0
Electroporation-MCF7 -1.0
Regulated-GATA6 -1.0
CCAAT Enhancer Binding Protein-ANIMAL 0.1111
Malignant-fight -1.0
FUNCTIONS OF REPRODUCTION-Anaphase Promoting Complex -1.0
ES-qRT-PCR -1.0
ES-Transfection 0.1111
derivatives-FAMILY MEMBER -1.0
Tissues-Proteolysis 0.1429
study use-Embryoid Bodies -1.0
mir-223-Granulocyte -1.0
Cancer-Take -1.0
HOPX-Show -1.0
pRB-Retinoblastoma Protein -1.0
GATA2-localisation -1.0
Mcl-1-FAMILY MEMBER -1.0
Progression-STANDING -1.0
Necrotic-Death Receptors -1.0
Pathways-GATA6 -1.0
mediated-INK4a -1.0
UP-Reported -1.0
miRNAs-Mice 0.0625
Lethal-Kinase 0.0833
Mouse, NOS-Reports -1.0
Regulated-HOPX -1.0
GATA2-PROTEINS -1.0
Crassa-Telophase -1.0
TET1-IDH -1.0
Progenitor-Transcript -1.0
study use-Cell types -1.0
mek-Tumor cells -1.0
Micro-tubule-Show -1.0
Repression-RB1 0.1
Mice-PC9 0.0
Tumor regression-STANDING -1.0
Tumors-Mutations 0.1429
Tumors-Transformation -1.0
mediated-RAS -1.0
transcription factor Nuclear Factor I-miRNA -1.0
Mesodermal-POU5F1 -1.0
model-Enhance -1.0
IDH-Lead 2+ 0.0
ACT-Individual -1.0
PC9-Activities 0.0
Breast Cancer-HEPATOCELLULAR CARCINOMA 0.3333
Tumor cells-Cell Growth -1.0
TRAF6-Cells 0.1
Phosphorylation Site-Box -1.0
shRNA-Differentiation -1.0
Feedback-System -1.0
TREAT-Pathway -1.0
AML-Redundant -1.0
Cells-Represent -1.0
Oct-4-Stem Cells -1.0
MDM2-Rodent -1.0
studies-IDH2 Mutation -1.0
mek-Result -1.0
-- Prostate Cancer-Absence 0.0
Repression-90% -1.0
Binding-VARIOUS -1.0
look-Protein A -1.0
WT1-depend -1.0
Relapsing-Clear cell Kidney Cancer -1.0
inhibitors-EGFR -1.0
anti-apoptosis-resistance Determinant -1.0
Normal cell division-EVENTS -1.0
kill-Kinase -1.0
IDH2 Gene-IDH -1.0
Granulocyte-specific -1.0
IDH-Isocitrate Dehydrogenase -1.0
studies-IDH2 Gene -1.0
ABT-737-Cytotoxic -1.0
Repression-Exhibit -1.0
WAS-RB1 0.1
Mouse, NOS-Renilla -1.0
ABT-737-therapeutics -1.0
Account #-Synthetic 0.0
Production-Metabolite -1.0
MIR-21-Fold -1.0
Immortalized-lead increased -1.0
Senescence-Cultured Cells -1.0
Human-Tumor specimens -1.0
WAS-90% -1.0
mir-223-Regulation -1.0
GATA6-Tumorigenesis -1.0
localisation-Roles -1.0
telomerase activity-INTERMEDIATE -1.0
Occur-IDH2 Mutation -1.0
Show-Cell Growth -1.0
TRANSCRIPTION FACTOR-GATA2 Transcription Factor 0.3333
Tissues-LATS2 -1.0
pRB-E2F-1 -1.0
KRAS-striking -1.0
Trigger-Show -1.0
combinations-Ionising radiation -1.0
KRAS-Pathway -1.0
caspase activity-Process -1.0
Show-N NOS -1.0
Development-Stimulated -1.0
Regulated-PC9 0.0
Entry-miRNA -1.0
Tumor Suppressor Proteins-Exhibit -1.0
DNA hypermethylation-Block -1.0
Mutant-Human gene -1.0
Regulated-Cells -1.0
Ras proteins-Oncogens 0.1
STK33-inhibitors -1.0
Block-INK4a -1.0
P53-MDM2 -1.0
Difference stage-VARIOUS -1.0
Necrotic-Show -1.0
Human-Plasmid 0.0625
Identified-Mutation -1.0
Identified--- Lung Cancer 0.0
EC Cell-CO -1.0
Flow-AS gene -1.0
Proteasome-degradation of cyclin -1.0
Rest-Deregulation -1.0
TRAF6-GATA2 -1.0
anti-apoptosis-ACUTE MYELOGENOUS LEUKEMIA -1.0
necroptosis-compromise -1.0
-- Leukemia-HEPATOCELLULAR CARCINOMA 0.0
Mutant-inhibitors -1.0
hTERT-Cell Survival -1.0
mir-223-All-trans Retinoic Acid -1.0
Transcriptional Networks-Cells 0.1111
Oct-4-Primitive -1.0
Stem-studies -1.0
Retinoblastoma Protein-Gene Mutation -1.0
Show-Proteolysis -1.0
TET2-Catalytic -1.0
Mouse, NOS-Development -1.0
Oncogene-Small Cell Lung Cancers -1.0
WT1-Tumor cells -1.0
cancer cells-Degraded -1.0
Proliferative-CYCLIN E -1.0
Binding-LATS2 -1.0
Leukemic Cells-Carrying -1.0
Branch-LABORATORY -1.0
model-TRAF6 -1.0
Trigger-Genotoxic Stress -1.0
Viability, Cell-Show -1.0
Catalytic-Tumors -1.0
Leukemic Cells-Metabolite -1.0
WAS-Tumors 0.2
Mcl-1-Reported -1.0
Human gene-GATA2 -1.0
KRAS-Genes -1.0
Identified-Pathways -1.0
Development-LATS2 -1.0
LEAD-STANDING -1.0
neoplastic transformation-EVENTS -1.0
bcl-xL-Mutation -1.0
Oct-4-Study -1.0
Mutations-2-HG -1.0
Cell types-Cancer -1.0
Resistance-Tumor cells -1.0
Breast Cancer-miRNA 0.1111
Tumorigenesis-Scientific -1.0
AN-Ubiquitin 0.1
Differentiated-Mouse, NOS -1.0
ES-TUMOR TISSUE -1.0
